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PREFACE
Although the HIV epidemic is still at an early stage in many countries in the Asia Pacific region, it poses a very
serious health and developmental problem. Given the size of the population in the region, representing 60%
of the world’s people, the potential for epidemic growth is very real. Since the extensive spread of HIV began
at the end of the 1980s, more than 6 million people in the region have become infected. In the year 2000 alone,
it is estimated that more than 500 000 died of AIDS in Asia – about 1500 a day.
Experience has shown that prevention and intervention activities can successfully bring about reductions in
HIV prevalence, provided they are combined with high-level political commitment and leadership. The priority
in the Asia Pacific region is to implement HIV interventions among those sections of the population with high-risk
behaviour, such as sex workers and their clients, injecting drug users, and migrant workers. There are many
success stories, such as in Thailand and Cambodia, where condom promotion activities have brought about
behavioural changes and a subsequent reduction in HIV prevalence and incidence  – a major achievement.
There are, however, still many areas of concern. Interventions are needed urgently to prevent HIV
relating to injecting drug use and high risk sexual behaviour and to scale up the coverage of these interven-
tions so that they have nation-wide impact on the HIV prevalence.
Very few countries with limited resources have been able to reduce HIV transmission, but, where activities
have been successful, they have been guided by adequate epidemiological knowledge. In planning any
intervention, it is necessary to develop an evidence base of relevant data. This joint SEARO/WPRO report on
HIV in the Asia Pacific region is an attempt in that direction. This is the first such report on which two WHO
regional offices have worked together, and augurs well for future collaboration between the two regions,
particularly in the area of HIV/AIDS. Within the framework of UNAIDS, WHO plays a leading role in the health
sector response to HIV/AIDS. Within that context, collecting data and analysing the current status and future
prospects for HIV/AIDS, including its implications, is an important priority for WHO. We hope that this report will
contribute to a better understanding of the epidemic in the Asia Pacific region and that countries will use the
information it contains to guide them in better responding to the HIV/AIDS epidemic.
Thanks to the commitment of  ministries of health, and with support from WHO,  most  Asia Pacific countries have
improved their surveillance systems in the past five years, and we now have more reliable data on the extent,
trends and determinants of the HIV epidemic in the region. We are also able to measure the impact of
interventions and to properly guide public health decisions concerning HIV/AIDS. If we now use that knowl-
edge to select the most appropriate interventions, we can make a difference.
Dr Uton Muchtar Rafei Dr Shigeru Omi
Regional Director Regional Director
WHO Regional Office for South-East Asia WHO Regional Office for Western Pacific
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       ABBREVIATIONS AND ACRONYMS
AIDS acquired immune deficiency syndrome
ANC antenatal clinic attendees
BSS behavioural surveillance survey
CDC Centers for Disease Control and Prevention
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HIV/AIDS in Asia and the Pacific Region
Introduction
The Asia Pacific region is vast and diverse.  In addition to countries with varied
epidemiological patterns of human immunodeficiency virus and acquired immu-
nodeficiency syndrome (HIV/AIDS) – high versus low HIV prevalence countries
and different predominant HIV risk behaviour(s) – countries in the region also
have extremely diverse capabilities to develop and support public health preven-
tion and control programmes.  In reviewing the current epidemiology of HIV/AIDS
in Asia, this diversity needs to be fully appreciated.
Understanding of the many diverse HIV epidemics and their determinants in the Asia-Pacific Region has
improved substantially over the past 3-5 years, as a number of countries have implemented comprehensive
surveillance systems for HIV prevalence, as well as sexual and injecting risk behaviours.  As of 2001, HIV
prevalence in most Asia Pacific countries remains low, but there are major public health concerns regarding
the future growth potential of HIV/AIDS in the region.  This vast region, with a population of nearly 3.5 billion
in the most sexually active age group (15-49 years) – representing nearly 60% of the world’s population –
has the potential, because of its sheer size, to significantly influence the course and overall impact of the HIV/
AIDS pandemic.
This report presents an overview of the HIV/AIDS pandemic and a more detailed description of the epidemi-
ology of HIV/AIDS in the Asia Pacific region.
The HIV/AIDS pandemic
Figure 1 shows the estimated temporal distribution of HIV prevalence in four of the major “regions” in the
world.  North American countries and countries in Western Europe, Australia and New Zealand are combined
into a grouping of “Western countries”.  Globally, only small numbers of HIV infections are estimated to have
occurred during the late 1970s and early 1980s.  The increasing HIV prevalence in sub-Saharan Africa
during the 1990s is clearly evident in this figure.  HIV was introduced into Asia Pacific countries during the
early to mid-1980s, and by the early 1990s the increasing spread of HIV in the region was also clearly
evident.
As of mid-2001, the HIV/AIDS pandemic comprises many separate and basically independent epidemics,
each involving different modes of HIV transmission and each developing at separate times and in different
countries.  Even within countries, HIV epidemics have primarily been localized and diverse.  What appeared
about two decades ago to be focal epidemics in industrialized countries that mainly involved men who were
having sex with other men (MSM) and injecting drug users (IDU), has evolved into a more complex
pandemic.  HIV/AIDS is currently endemic at varying, but usually high, prevalence levels among MSM in
most regions of the world.  Explosive spread of HIV still occurs within pockets of susceptible IDU populations
worldwide and sexual transmission occurs throughout the world among both males and females who have
unprotected sex with multiple partners.  However, extensive heterosexual spread of HIV has occurred
1
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predominantly only in sub-Saharan African countries, a few countries in the Caribbean and in Central
America, and a few countries in south and south-east Asia.
HIV/AIDS in Asia
HIV/AIDS in Asia was first detected in the early to mid-1980s.  Initial AIDS cases were detected among MSM
in several Asia Pacific countries such as Australia, Japan, Malaysia, New Zealand, Singapore, and Hong
Kong during the early 1980s.  A relatively extensive spread of HIV occurred in MSM sex networks in these
Asia Pacific countries and such transmission probably peaked during the mid-to-late 1980s.
By the mid-to-late 1980s, it became evident that transmission of HIV was also increasing among other major
HIV-risk behaviour groups in Asia.  High HIV prevalence (up to 50% or more) was documented among
female sex workers (FSW) in Thailand and in parts of India, notably Mumbai (Bombay), during the mid-to-late
1980s.  In addition, intense focal HIV epidemics were documented in Thailand, parts of northeast India, and
the “golden triangle” area (where the borders of China, Myanmar and Thailand meet) in IDU populations
beginning around the mid-to-late 1980s.
During the 1990s, in several south and south-east Asian countries (Cambodia, parts of India, Myanmar and
Thailand), significant heterosexual transmission of HIV continued or was first noted, primarily from FSW to their
male clients, and then from those infected males to their regular sex partners.  An explosive spread of HIV
within IDU populations, which can lead to infection levels of over 50% within a year or two, continued to occur
in several provinces of China, north-east India, Malaysia, Myanmar, Pakistan, Thailand and Viet Nam, and
most recently, in the late 1990s, in Indonesia and Nepal.  Although HIV can spread rapidly among IDUs who
share contaminated injecting equipment, and from them to their sex partners, these epidemics have, so far,
resulted only in limited spread of HIV to the heterosexual population at large.  The highest HIV prevalence rate
reached in a few Asian countries with extensive heterosexual HIV transmission has only been about one tenth
of the highest prevalence rates found in some sub-Saharan African countries.
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Estimated regional
HIV prevalence
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In Asia Pacific countries with a measurable HIV prevalence rate, the prominent risk behavioural groups are
FSW and/or IDU.  As a result, there is usually a marked male preponderance of HIV infections compared with
female infections.  This is because most IDU are male, and the epidemiology of FSW and their male clients in
most Asian countries also results in a preponderance of infected males.  A relatively small “core” group of
highly exposed FSW can develop very high HIV infection rates and transmit infection to their many male
clients.  This accounts for the very large male preponderance of HIV infections in the early phase of a
heterosexual HIV epidemic in Asia Pacific countries.  In the latter phases of an Asian heterosexual HIV
epidemic, the male to female ratio begins to decrease as infected males begin to infect their regular female sex
partners (i.e., their wives or girl friends).
By the beginning of the new millennium, the Asia Pacific region had less than 20% of the estimated HIV
infections in the 15-49 year old population, as shown in Figure 2.  The estimated adult HIV prevalence rates
in the region varied from almost zero (Democratic People’s Republic of Korea) to 2-3% in Cambodia,
Myanmar, Thailand, and in several major states in India.
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From a regional perspective, the magnitude and short-term trends of HIV in Asia Pacific countries are and will
continue to be dependent largely on the success of HIV prevention and control programmes, essentially in
countries:
1 where the extensive heterosexual HIV transmission is occurring, especially in those countries with
the highest HIV prevalence (Cambodia, Myanmar, Thailand and several large states in India); and
2 which have large population sizes such as China, India and Indonesia.
Basic epidemiology of HIV
With the exception of HIV transmission from mother to child and via infected blood/blood products, tissues or
organs, all other HIV transmission occurs only as a result of those human behaviour(s) that place an individual
at  risk of acquiring an HIV infection.  The primary risk behaviours that place a person at significant risk of
acquiring or transmitting an HIV infection include the sharing of drug injecting equipment and/or having
unprotected sexual intercourse with multiple sex partners.  Only those persons who are involved in some
HIV-risk behaviour(s) or whose sex partner is involved in some HIV-risk behaviour(s) are at any risk of
acquiring an HIV infection via sexual intercourse.
The epidemiological dynamics of HIV infection are different from other infectious disease agents, including
other sexually transmitted infections (STI), because the risk of HIV transmission via sexual intercourse is very
low compared to most other STI.  In the absence of facilitating factors, the transmission of HIV via a single
episode of anal or vaginal intercourse is very low.  Several epidemiological studies indicate that, in the
absence of facilitating factors, the efficiency of vaginal intercourse for HIV transmission is about 1 or less per
1000 sex exposures 1,2.  The risk of HIV transmission via anal intercourse is generally believed to be higher
than via vaginal intercourse, but the risk of HIV transmission via anal intercourse is still believed to be low
when compared with other STI.
For extensive sexual transmission of HIV to occur, a pattern of concurrent or overlapping sex partners and
a high frequency of sex partner exchanges along with a high prevalence of such behaviours must be present.
These behavioural parameters can then generate two of the most important facilitating factors: (1) concurrent
genital ulcerative lesions from other STI, and (2) a relatively high proportion of new and/or recent HIV
infections that are very infectious compared with HIV infections of longer duration.  Higher sex partner
exchange rates for FSW and a larger proportion of males who visit FSW on a regular basis were found to be
important factors in a couple of high HIV prevalence countries in Asia compared with two low HIV prevalence
countries in Asia 3.
Several epidemiological studies have shown that male circumcision is associated with a reduced rate of HIV
acquisition 4,5.  However, it is difficult to assess the extent to which these findings may be confounded by
fundamental differences between populations with different rates of male circumcision—i.e., differences in
social-sexual patterns and prevalence of high-risk sexual behaviours.  It is also possible that the relative
protective effect of male circumcision may be correlated with the general level of genital hygiene, and lack of
or poor genital hygiene in circumcised males may override any relative protective effect of circumcision.
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Annex 1 provides a review of the natural history of HIV infection.
Annex 2 reviews the present knowledge on mother- to- infant transmission of HIV  and the prevention of
mother- to- child transmission of HIV in the context of the Asia Pacific Region.
Major HIV-risk behaviour groups (RBG) in Asia
The patterns and prevalence of the major HIV-risk behaviours in Asia are different from other major geographic
regions of the world.  In sub-Saharan Africa, the predominant mode (over 95%) of HIV transmission in the
sexually active population is via heterosexual intercourse.  In “Western” countries, MSM and IDU groups
continue to be the most prominent RBG involved in HIV transmission.  In Asia, IDU, as well as FSW and their
clients, are the most prominent RBG involved in HIV transmission.  The following are descriptions of the major
HIV RBG in Asia.
MSM
As in all societies around the world, MSM are believed to comprise about 5-10% of all sexually active males
in most Asia Pacific countries.  However, MSM in Asia represent a diverse group that cannot be easily
identifiable for intervention or for public health surveillance.  MSM constitute an ill-defined group in Asian
society and include men who both sell and buy sex, as well as those who exclusively practice homosexual
behaviour and others who are bisexual.  Many of these men are married, and all socioeconomic levels are
represented in this group.  In some settings, biological males who maintain a transvestite lifestyle or a
transgender identity may also be part of the MSM community.  They represent one of the highest-risk groups
for acquiring or transmitting HIV because undefined proportions of them routinely have multiple and concurrent
sex partners.  However, the structure and patterns of MSM groups who routinely have multiple sex partners,
especially their general and local sex networks within Asia, are widely unknown.
A relatively extensive spread of HIV occurred in MSM sex networks in many Asia Pacific countries/cities
during the mid-to-late 1980s.
IDU
The Asia Pacific region has been significantly affected by drug-related HIV epidemics.  The association of IDU
and HIV infection in Asia comprises very dynamic and rapidly changing patterns of drug and injecting drug
use.  New drugs are constantly appearing and new populations are then caught up in injecting drugs.  In most
countries in south and south-east Asia, IDU have usually been the first HIV RBG detected with extensive HIV
transmission.  Drug users in Asia Pacific countries are rapidly switching from non-injecting drugs to injecting
drugs resulting in many explosive HIV epidemics.  Examples include some provinces in southern China, in
Delhi and north-east India, and most recently, during the late 1990s, in Nepal, where HIV prevalence has
rapidly reached levels of 50% or higher among IDU.  Other Asia Pacific countries and locations such as
Myanmar, Malaysia, Pakistan, and Viet Nam have also reported extensive HIV transmission in their IDU
A relatively
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in MSM sex
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populations.  Data from Indonesia for the years 1999-2000 indicate that HIV prevalence is rising rapidly
among IDU populations throughout the country.
Epidemiological observations over the past 15 years have shown that HIV transmission from HIV-infected IDU
(mostly young males) to some of their regular or steady sex partner(s) is occurring.  Similarly, infected male
clients of FSW can be expected to transmit their infection to some of their wives or girlfriends.  However, the
average reproductive number (Annex 3) of HIV in these groups is generally below 1 and, as a result, further
penetration or spread of HIV to the general population has not been documented to any significant degree.
HIV epidemics associated with IDU and other HIV RBG are often independent of each other.  These
epidemics can emerge and evolve separately – with minimum crossover – as exemplified by the two concurrent
HIV epidemics of different subtypes in Thailand, one among IDU and the other among high-risk heterosexuals
6.  Nevertheless, the high prevalence of HIV infections in some IDU populations serves as a constant potential
source for introduction of HIV to other RBG such as MSM or FSW.
Heterosexuals with multiple sex partners (Annex 4)
HIV is primarily an STI.  As with all other STI, the major driving force of the HIV pandemic is heterosexual
transmission.  This is because heterosexuals constitute the vast majority (about 90% or more) of all national
populations, compared with the much smaller numbers of IDU and MSM.  Although high rates of HIV infection
have been found, and may still occur in susceptible pockets of IDU and MSM, more than 90% of the global
total of HIV infections have been, and will continue to be due to heterosexual transmission.  HIV prevalence
in most countries will generally not exceed 0.5% of the total 15-49 year-old population unless some extensive
HIV transmission occurs within the heterosexual population.
Studies of sex networking in south-east Asia have classified heterosexual multi-partner relationships into three
types: commercial sex only; noncommercial sex only; and a combination of commercial and noncommercial
sex 7.   These studies and other research on sexual behaviour suggest a general pattern for Asia – in contrast
to Africa, North America and Europe – of cultural and social norms that restrict the majority of females from
premarital and extramarital sex.  This view is further supported by behavioural data collected from 16 developing
countries in Africa, Asia, and Latin America in 1989-90 through the World Health Organization’s Global Programme
on AIDS (WHO/GPA).  Single women in the Philippines, Singapore, Sri Lanka and Thailand reported rates of
sexual intercourse far lower than their African (nine countries) and Brazilian counterparts 8.
Within the Asia Pacific region, FSW have the highest sex partner exchange rates and therefore represent the
most significant core group for heterosexual transmission.  The critical factors influencing the rate of spread
from FSW include the number of clients per day and the proportion of males who regularly visit sex workers.
In Cambodia, Myanmar and Thailand, HIV prevalence among FSW has risen to over 50% in many areas.
Similarly, in India, where the sex trade is large, in some cities up to half or more of FSW are infected.  Even in
Papua New Guinea, where formal brothels and red light districts do not exist, HIV levels among urban floating
   WHOHIV/AIDS in Asia and the Pacific Region 2001
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sex workers reached 16% in 1998.  Sex work continues to be illegal in virtually all Asia Pacific countries and,
therefore, it is often hidden and clandestine, which makes prevention interventions difficult.
Low rates of premarital sex among single women, combined with high rates of commercial sex patronage
among men – a pattern found in Cambodia and Thailand, for example – create the opportunity for substantial
HIV epidemics in the core populations of FSW and their male clients.  In Asia Pacific countries other than
Cambodia, Myanmar, Thailand and parts of India, the prevalence and frequency of heterosexual risk
behaviours do not appear to be sufficient to fuel extensive heterosexual HIV transmission.  A probable
exception to the prospects of continued low HIV prevalence may be Papua New Guinea, where there
appears to be a slow but steady increase in heterosexual transmission of HIV.
HIV situation in Asia Pacific countries
The HIV situation analysis is based on results from HIV/AIDS case reporting, HIV sentinel surveillance and
other sources, such as mandatory testing among blood donors, specific surveys, etc. (Annex 5, Annex 6).
Table 1 lists all Asia Pacific countries in rank order by their estimated HIV prevalence rate along with some
assessment of the major RBG affected.  In general, when extensive spread of HIV is occurring primarily in
MSM and/or IDU populations, the total national HIV prevalence level will be in the general range of about
0.5% or less.  Only when extensive HIV spread occurs among heterosexuals will national HIV prevalence
levels begin to exceed 1%.  As of 2001, only three Asian countries have an estimated national prevalence rate
greater than 1% in their 15-49 year-old population—Cambodia, Myanmar and Thailand.
Projected impact of HIV/AIDS in Asia Pacific countries
The clinical burden of HIV infections that can be expected over the next five years in Asia Pacific countries is
directly related to their current HIV patterns and prevalence rates and can, therefore, be reliably projected
using a scenario/modelling method (Annex 8).  In Asia Pacific countries that currently have a low HIV
prevalence (less than 0.1%), annual AIDS deaths are projected to be less than 1% of all adult deaths
throughout the first half of the coming decade.  The clinical impact of AIDS and other HIV-related conditions in
the seven Asia Pacific countries with moderate HIV prevalence (>0.1% and <1% of the 15-49 year-old
population) will increase annual adult deaths by about 5% during this coming decade, with most of these AIDS
deaths among young male IDU.  For the high HIV prevalence countries (Cambodia, Myanmar, Thailand and
a few states in India), annual AIDS deaths will increase the total annual deaths in the 15-49 year-old
population by up to 40%.
It is estimated that more than 500 000 individuals died of AIDS in 2000 and that this number will reach about
800 000 by 2005 (Table2). The highest number of deaths is expected to occur in China, India, Myanmar and
Thailand. The burden of AIDS cases on health services will be particularly high in Cambodia, Myanmar,
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 W
HO         Population   Number    HIV
           Country              15-49       HIV+ Prev (%) HET MSM IDU1
Cambodia            6 091 000    169 000 2.77 +++ — —
Myanmar          25 768 000    510 000 1.99 +++ — ++
Thailand*          36 241 000    671 000 1.85 +++ — ++
India        522 862 000 3 900 000 0.75 ++ — +
Papua New Guinea            2 450 000      15 000 0.60 ++ — —
Malaysia          11 654 000      42 000 0.36 — — ++
Nepal          11 259 000      34 000 0.30 + — ++
Viet  Nam          42 275 000    122 000 0.29 + — ++
Singapore            2 027 000         3900 0.19 — + —
Australia            9 543 000      12 000 0.13 — ++ ++
Pakistan          72 468 000      73 000 0.10 — — ++
Indonesia        116 009 000    100 000 0.09 — — ++
China        720 355 000    600 000 0.08 — — +++
Sri Lanka          10 572 000         8500 0.08 — — —
Fiji               429 000           300 0.07 — — —
Hong Kong, China            3 918 000         2500 0.06 — + —
New Zealand            1 939 000         1200 0.06 — + +
Maldives               131 000         <100 0.05 — — —
Lao PDR            2 402 000         1300 0.05 — — —
Philippines          38 428 000      10 000 0.03 — — —
Bangladesh          68 021 000      13 000 0.02 — — —
Japan          58 098 000      10 000 0.02 — + —
Rep of Korea          22 700 000         3800 0.01 — — —
DPR Korea          13 270 000         <100 <0.01 — — —
Mongolia            1 411 000         <100 <0.01 — — —
Bhutan               938 000         <100 <0.01 — — —
Brunei Darussalam               178 000         <100 Low — — —
Other Pacific            1 300 000         1300 <0.01 — — —
Island countries
Total                                1 802 737 000 6 304 300
                     Comments
* Extensive HIV spread among  FSW and
 their male clients, but limited spread from
infected  clients to their sex partners.
* Major diversity among states.
* Increasing heterosexual transmission.
* Extensive HIV spread among IDU cohorts,
but limited spread to other high HI- risk
 behaviour cohorts.
* Initial MSM importations.
* Primarily MSM and IDU
* Diverse patterns and spread among IDU.
* Recent IDU epidemics
* Primarily focal IDU epidemics
* Initial MSM importation
* Primarily MSM
* Low HIV prevalence among all HIV-risk
behaviour cohorts.  The vast majority of
HIV infections are imported with some
limited transmission from these imported
infected persons to their steady or regular
sex partners.
Data source – UNAIDS/WHO Global Report (June, 2000, estimated for the year 1999) –with more recent estimated numbers (for the year 2000) for
Cambodia, China, India, Indonesia, Malaysia,  Papua New Guinea, the Philippines, Sri Lanka, Thailand and Viet Nam, with prevalence rates based on the
15-49 year-old population of 2000 as the denominator -  * estimates in 2001.
( __  ) Unknown or minimal HIV transmission; (+)  limited HIV transmission; (++) moderate HIV transmission; and (+++)  major HIV transmission
Table 1: Estim
ated HIV prevalence and m
ajor mode(s) of HIV transmission in Asia Pacific countries, 2000
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Thailand and certain parts of India. Efforts are urgently needed in the most affected countries to strengthen the
capacity of health services to support individuals with AIDS and to reduce the stigmatization and discrimination
against families and individuals affected by AIDS.
The estimated number of paediatric AIDS cases and maternal AIDS orphans is directly related to the number
of HIV-infected females of child-bearing age and their fertility rates (Annex 2).  HIV prevalence is low in most
Asia Pacific countries and the predominant HIV-risk behaviour populations are IDUs, who are predominantly
male, FSW and their male clients.  The male-to-female ratio of HIV infections in most Asia Pacific countries is
generally many more males than females. These factors (generally low HIV prevalence, a much higher male-
-Aids deaths: based on the estimate of HIV prevalence in 2000 and estimated shape of the annual HIV incidence
  curve  using standard survival of 9 years (Thailand: acccording to Thai working group on HIV/AIDS projection)
- AIDS cases used in some countries: *estimated by country level, **estimated by UNAIDS/WHO working group
-No Estimation/projection of AIDS/deaths developed:  *** newly reported AIDS cases per year;
  **** very few reported AIDS cases.
Table 2: Estimated and projected annual numbers of AIDS deaths
among the 15-49 year-old population in  Asia, 2000 and 2005
Country
         Country    2000     2005
India     350 000     500 000
Thailand       55 000     >50 000
Myanmar**       46 600     >55 500
China       20 000       80 000
Cambodia      >11 000     >24 000
Bangladesh **      >11 000       17 000
Viet Nam*          4000      >11 000
Pakistan          3500        11 000
Indonesia          3000       18 000
Nepal          3000          6000
Malaysia          2400        >6000
Papua NG            750          2400
Sri Lanka            500        >1000
Philippines            200            750
Japan            650            650
Rep. of Korea            250            350
Lao PDR          <100          >200
Australia*            190            190
Singapore*            140            220
Hong Kong, China***              60              60
New Zealand ***              27              27
Brunei              <5              <5
Macau, China ***                3                3
All Pacific islands ***              10              10
Bhutan****
Mongolia****
DPR Korea****
Maldives****
Total >500 000 >784 000
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to-female ratio of HIV infection), plus a low age-specific fertility rate, accounts for the relatively low prevalence
of mother-to-child transmission of HIV in the Asia Pacific region.  With the possible exception of the few high HIV
prevalence countries in south and south-east Asia, current and projected numbers of paediatric AIDS cases
and maternal AIDS orphans in most Asia Pacific countries are expected to remain low.
Persons with latent infection with Mycobacterium tuberculosis (Mtb) and who are also infected with HIV
develop clinical tuberculosis at an increased rate.  Modelling of the interaction between HIV and Mtb infections
provides useful estimates and projections of the additional tuberculosis cases that may be expected annually
in different epidemiological situations. The prevalence of Mtb infection among young and middle-aged adults
in Asia Pacific countries is relatively high (ranging from 35% to over 70%).  However, HIV prevalence levels
in Asia Pacific range from much less than 0.1% in most countries up to 2-3% only in Cambodia, Myanmar,
Thailand and parts of India.
In Cambodia, under the worst-case scenario, the annual number of HIV-related tuberculosis cases in the 15-
49 year-old population could, by the end of the coming decade, equal the total expected annual number of
tuberculosis cases that would occur in the absence of HIV.  Most Asia Pacific countries with current low HIV
prevalence can expect to have an increase of HIV-related tuberculosis – from 5-10% or less.
Current and future challenges to HIV/AIDS prevention in Asia
The common thread that runs through all extensive or epidemic transmission of HIV in Asia is that the primary
HIV RBG affected are all socially marginalized and engage in socially unaccepted and often illegal behaviour(s).
Injecting drug use and high sex partner exchange rates are difficult subjects for government or official
agencies to deal with.  Urgent and universal support for primary prevention and behaviour change pro-
grammes has not yet materialized.
Public health interventions
The available interventions for prevention of HIV transmission should be separated into immediate and short-
term interventions in contrast to longer-term interventions.  Examples of immediate or short-term interventions
are those often referred to as “risk-reduction” and “harm-reduction” interventions – routine and consistent
condom use with commercial or casual sex partners and provision of safe drug injecting equipment.  These
interventions are universally accepted and recommended by virtually all HIV/AIDS programmes, but remain
controversial because opponents of these measures believe that acceptance of these interventions may
condone HIV-risk behaviours and/or will tend to promote such behaviours.  The primary example of a longer-
term intervention is the reduction, modification or elimination of HIV-risk behaviours – having multiple sex
partners, especially on a concurrent basis and/or the recreational use of legal or illegal drugs.  These latter
interventions are also universally accepted, but, in addition to taking decades or generations to effect
meaningful behavioural change, they remain difficult to achieve because the science or art of changing human
behaviour (i.e., cigarette smoking, healthy diet and exercise, etc.) is still developing.  Ideally, both types of
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interventions (immediate and longer-term) should be fully implemented, but, as pointed out above, the imme-
diate risk-reduction and/or harm-reduction interventions remain controversial or illegal.
Competition for limited HIV/AIDS programme support
The basic objectives of all national AIDS programmes are to prevent HIV infection and provide care to those
infected.  With unlimited resources, attainment of both objectives might be possible. However,  with limited
resources, a natural tension and competition for resources exists between prevention/control programmes
and treatment/care programmes.  In the Asia Pacific region, only a few countries/city states (i.e., Australia,
Hong Kong, Japan, the Republic of Korea, New Zealand and Singapore) have adequate resources to
support both types of programme.  In most other Asia Pacific countries, there are insufficient resources to
adequately support prevention programmes and, therefore, the cost of routine anti-HIV drug treatment is out
of reach.
The dilemma confronting most Asia Pacific countries is whether funds should be divided to provide some
support for both types of programme. Most policy-makers are hesitant to make the difficult policy decision to
maximize government support to primary prevention programmes.  This is especially difficult when the choice
may, in some instances, be between providing funds for needle-exchange programmes or for anti-HIV drugs
to treat infected children. For most Asia Pacific countries, the tension and competition between HIV prevention
and treatment/care programmes will continue and, as a result, risk-reduction and harm-reduction programmes
that are required for effective prevention of HIV in the Asia Pacific region may continue to be underfunded.
With only a few exceptions, most national HIV/AIDS programmes in Asia are underfunded.  In virtually all of
the poorer Asia Pacific countries, many foreign donors have provided support for specific projects, such as
outreach programmes for FSW or IDU populations in a few selected districts.  The resultant patchwork of HIV/
AIDS projects leads to very incomplete national coverage for any of the risk-reduction and/or harm-reduction
interventions needed in the highest HIV RBG in the country – IDU and FSW.  The future of HIV/AIDS
prevention/control programmes in most poor Asia Pacific countries will also depend on how well external
donors can increase their current HIV/AIDS support.
HIV/AIDS in Asia and the Pacific in the new millennium
In the few Asian countries where extensive HIV transmission has occurred during the past decade (Cambo-
dia, Myanmar, Thailand and parts of India), the most recent HIV surveillance data indicate that HIV preva-
lence peaked in these countries during the mid-to-late 1990s.  However, during the coming decade, HIV
prevalence in these countries is not expected to decrease rapidly, but will likely persist at around 2-3%
because HIV transmission from infected FSW and infected male clients of FSW to their regular sex partners will
continue to occur at a steady pace.
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In Asia Pacific countries where extensive HIV spread has occurred primarily in IDU populations (China,
Indonesia, Malaysia, Nepal, Pakistan, Viet Nam and parts of India), this HIV pattern is projected to continue
with little change during this decade.  Public health interventions, directed at minimizing HIV transmission
among IDU groups, can only be effective if these interventions are fully supported by national governments.
However, HIV sentinel surveillance focused on FSW and STI patients in these countries should be sufficient
to provide adequate warning should extensive heterosexual HIV transmission begin.  In the absence of
extensive heterosexual transmission, HIV prevalence rates in the total 15-49 year-old populations of these
countries are not expected to increase to much more than about 0.5%.
The exact dynamics, quantitative aspects, and mix of epidemiological parameters (patterns and prevalence of
sex partner exchange, temporal presence or absence of facilitating factors, etc.), needed to ignite extensive
heterosexual transmission of HIV or to determine how high HIV prevalence may reach, are not known with
any degree of certainty.  In Asian countries where no extensive heterosexual transmission of HIV has
occurred, but where pockets of high heterosexual HIV-risk behaviours exist, some extensive HIV transmis-
sion may occur when, and if a sufficient number of HIV infections are permitted to accumulate.  In addition, in
countries where the patterns and prevalence of sexual risk behaviours are increasing, the potential for
extensive heterosexual HIV transmission will also increase.  HIV/AIDS will, therefore, continue to pose an
immense challenge to public health workers throughout the region because all the major HIV-risk behaviours
are present in virtually all Asia Pacific countries, albeit in significantly varying patterns and degrees.
Regardless of what the future growth potential of HIV/AIDS may be in the Asia Pacific region, the only
responsible public health action to take involves focusing HIV/AIDS interventions on the highest HIV RBGs.
From all the HIV/AIDS epidemics that have occurred in Asia Pacific countries, it is clear that sustained
heterosexual HIV transmission will only occur in those populations with sufficient heterosexual risk behav-
iours.  In addition, it is also clear that the first evidence of extensive heterosexual transmission of HIV will be
found among FSW and STD patients, and current HIV surveillance systems in most Asia Pacific countries are
capable of detecting HIV prevalence rates when they reach 1% or more in these RBGs.
To ensure that extensive HIV transmission will not occur, or will not continue to occur in Asia Pacific countries,
public health programmes must fully implement the “100% condom programme” for all commercial and casual
sex encounters.  Such programmes are urgently needed in current high HIV prevalence countries and in
present low HIV prevalence countries before HIV prevalence rises to detectable levels.  The 100% condom
intervention effectively focuses on all commercial and casual sex encounters, and has been estimated to have
prevented several million HIV infections in Thailand during the 1990s.  However, in current high HIV
prevalence countries, there is also an urgent need to address the slow but continuing problem of HIV
transmission from infected FSW and/or infected male clients to their regular sex partners, since the 100%
condom programme does not target regular sex partners.  Similarly, where HIV prevalence is high or still low
among IDU populations, public health programmes should aggressively implement, or at least fully support
harm-reduction programmes for IDU groups to prevent HIV transmission in this very vulnerable RBG.
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The extent  to which current national HIV prevalence levels in Asia Pacific countries may increase in the new
millennium will depend on how effective national AIDS programmes are implementing risk-reduction and
harm-reduction interventions in FSW and IDU populations.
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Country Status
This section of the report  provides additional details on the HIV/AIDS situation for
each country in the Asia Pacific region.  Countries will be presented in a descend-
ing order, starting with countries with the highest estimated HIV prevalence rate to
those countries with the lowest estimated HIV prevalence rates.
The HIV/AIDS situation in each country will be presented, along with an estimate
of the annual number of AIDS deaths that can be expected in the years 2000 and
2005.  These estimates of AIDS deaths are based on the estimate of HIV preva-
lence in the year 2000 and on the estimated shape of the annual HIV incidence curve (Annex 8).  In this
report, annual AIDS deaths will be calculated based on a standard median survival interval of 9 years.
As described in the first section of this report, only countries where extensive heterosexual transmission of HIV
has occurred have an HIV prevalence rate in their 15-49 year-old population of more than 1%.  These areas
include Cambodia,  Myanmar,  Thailand and several major states in India.  In countries where extensive HIV
transmission has occurred primarily only in IDU and/or MSM, estimated national HIV prevalence has gener-
ally been more than 0.1%, but less than 1%.  These countries include Australia, Nepal,  Indonesia, Malaysia,
Viet Nam, and Pakistan.  All the other Asia Pacific countries where no extensive or only limited HIV transmis-
sion has been detected have low HIV prevalence (less than 0.1%).
 Group I – High HIV prevalence countries
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Cambodia
Cambodia is a  country with a total estimated population in 2000 of about 12 million, with about 6 million in the
15-49 year-old age group. Cambodia lies in the south-western Indo-Chinese Peninsular in south-east Asia.
It is bordered by the Lao People’s Democratic Republic, Thailand and  Viet Nam, and by the Gulf of Thailand.
Cambodia has a developing economy and is one of the world’s poorest countries, with a per capita gross
national product (GNP) in 1999 of $280.
HIV infections were first detected in Cambodia through serological screening of blood donors in the early
1990s.  However, the general magnitude of HIV transmission in the country was not fully described until the
completion of the first HIV sentinel surveillance (HSS) round in 1995.  HIV sentinel groups that year included
eight different populations in nine provinces located mainly on the Thai border, where HIV infections were
suspected to be high. The results provided the first evidence of a highly disseminated HIV epidemic, with
prevalence of HIV up to 38% among FSW, 8% among police and the military, and about 2.5% among women
attending antenatal clinics (ANC).
Extrapolating from data collected from continued annual HSS rounds, HIV prevalence in Cambodia was
estimated at the end of 1997 to have reached a high of over 200 000 infections in the total 15-49 year-old
population.  HSS data collected in 2000 indicate that HIV prevalence has decreased in all sentinel groups and
Source: MOH Cambodia
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that national HIV prevalence has peaked and may be declining, as it has in Thailand (Figure 3).  The
estimated national HIV prevalence for the year 2000 is 169 000 (2.8%) and remains the highest estimated
prevalence rate in the Asia Pacific region.
The first HIV Behavioural Surveillance Survey (BSS) in Cambodia was started in 1997.  A preliminary
behavioural survey on a small scale was conducted one year before.  From 1996 to 1999, the consistent
condom use rate increased from 15.7% to 78% among sex workers (Figure 4), and from 45 % to 81%
among the police.  Some studies have reported that about 60% of the Cambodian police force have visited
sex workers in the past year.  These findings clearly reflect the increasing programme activities on condom
promotion in sex work in this country. The BSS also showed that the partner exchange pattern in this country
is one of the highest in the Asia Pacific region.  The mean number of clients in the previous night was 3.2 per
sex worker.
STI prevalence surveys in Cambodia were planned to be undertaken in 1996, 2000 and again in 2003.  In
1996, STI prevalence rates were found to be high among sex workers.  These rates varied by site and
ranged from 4-19% for syphilis (confirmed by TPHA), 17-26% for Chlamydial infection (by LCR) and from
20-34 % for gonorrhoea (by culture).
Based on an estimated HIV prevalence of 169 000 in the year 2000, the clinical case load of AIDS deaths,
as well as HIV-related tuberculosis cases can be estimated and projected with some confidence up to the
year 2005.
In the Asia Pacific region, Cambodia, even prior to the introduction of HIV/AIDS, had one of the highest
estimated annual mortality rates (from all causes) in the total 15-49 year-old population – about 6-7 per 1000
per year. Thus, even in the absence of AIDS, over 30 000 deaths  were  expected to occur in this age group
 in the year 2000.  The estimated annual number of AIDS deaths in this age group in Cambodia ranges from
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over 11 000 in the year 2000 and gradually increases to more than double (24 000) in the year 2005, an
increase in total deaths in this most productive age group of from about 35% to 80%.
The expected numbers of HIV-related tuberculosis cases in the 15-49 year-old population in the year 2000
is 5000-6000 and, by 2005, this number is projected to increase to about 10 000 cases.  These numbers
represent an increase in the total tuberculosis case-load in this age group of close to 15% in the year 2000,
and over 20% in 2005.
Overall, the clinical case burden of HIV-related disease(s) and conditions estimated and projected for Cambo-
dia will be the most severe in the Asian Pacific region. Cambodia  will require much additional technical and
fiscal support to adequately respond to these severe medical and social problems.
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Myanmar
Myanmar shares borders with Bangladesh, China, India, the Lao People’s Democratic Republic and Thai-
land. Its estimated total population in 2000 was close to 49 million, with about 25 million in the 15-49 year-old
age group.  Myanmar is one of the least densely populated countries in Asia, and the rugged, forested portion
of its terrain is still only lightly settled – it is a land of villages, where fewer than one-fourth of the people live in
urban areas.  The annual rate of growth of the population is somewhat high by world standards but is about
average for south-east Asia.  Myanmar has a centrally planned, developing economy that is largely nation-
alized and is based principally upon agriculture and trade.  The GNP per capita, however, remains one of the
lowest in the world.
HIV was probably introduced  to Myanmar in the mid-to-late 1980s.  HIV prevalence among IDU in the capital,
Yangon, had reached 73% by 1989.  Since then HIV infection rates among IDU tested in Yangon and
Mandalay have ranged from over 50% to 85%.  HIV prevalence among sex workers tested in Yangon and
Mandalay has increased from a median of 4% in 1992 to 26% in 1997.  HIV prevalence among ANC tested
in Yangon and Mandalay increased from no evidence of infection in 1992 and 1993 to 0.8% in 1995.  HIV
prevalence among ANC remained about 2% in 1998, 1999 and 2000. Outside the major urban areas, HIV
prevalence among some ANC tested in 2000 reached up to 5%.  HIV infection among military recruits tested
in Yangon and Mandalay increased from 0.5% in 1992 to 1.4% in 2000.
There are two HSS sites – one each in the largest cites in Myanmar (Yangon and Mandalay) - for FSW and
military recruits and six (6) sites for IDU.  For ANC attendees, there have been a total of 17 HSS sites, and all
of these sites are in urban areas.  These HSS sites were selected to include populations suspected  to be at
Sentinel population Myanmar Thailand
IDU     62.7%    47.2%
Direct FSW     38.0%     18.5% (33.2)*
Male STI Patients       7.1%      5.9%
Military Recruits       1.4%      1.4%
ANC       2.15%      1.46%
Highest level reached in 1994
HIV/AIDS situation
Table 3:  2000 HIV Sentinel Surveillance Findings in Myanmar and Thailand
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the highest risk of HIV and thus, should not be considered representative of the population in Myanmar,
especially of the rural population which comprises over 70% of the total population.
Rates and general trends of HIV infection in IDU, sex workers, and pregnant women are similar to those found
in Thailand.  The 2000 HIV sentinel surveillance findings are presented in Table 3.
The general HIV patterns and prevalence in Myanmar are also very similar to those observed in Thailand.
However, there are a few major differences in HIV trends in Thailand compared to Myanmar:
• HIV prevalence peaked among direct and indirect FSW in Thailand around the mid-1990s and has
been decreasing since then.  In Myanmar, HIV prevalence among direct FSW appears to be still
increasing, although some stabilization seemed to be noted in 2000.
• HIV prevalence in Thailand among ANC peaked at slightly over 2% in the mid-1990s and has
been slowly decreasing to about 1.5% in the year 2000.  Up to 2000, there does not appear to be
any peaking of HIV prevalence rates among ANC in Myanmar.
• HIV prevalence in military recruits in Thailand also appeared to have peaked in the mid-1990s and
HIV prevalence may have peaked in military recruits in Myanmar in 1999.
• All of the available HIV/AIDS data indicate that the peaking of HIV prevalence among FSW in Thailand
was a direct result of the “100% condom programme”, started by the Thai AIDS Programme for FSW
and their male clients during the early 1990s.  A 100% condom programme was started on a pilot basis
in late 2000 in four townships in Myanmar.  It is, however,  too early for these pilot programmes to have
had any measurable effect on HIV prevalence among FSW in Myanmar.
UNAIDS has made a prevalence estimate for Myanmar using the reported HSS data up through 1999.  The
UNAIDS estimate considered the reported HSS data to be representative of the total population.  The
Myanmar MOH  believes that the HIV prevalence estimate of UNAIDS is too high.  However, in the absence
of an official HIV prevalence estimate, this report will use the UNAIDS estimate to calculate the potential clinical
impact of HIV in Myanmar.
Based on some limited behavioural surveillance started in 1997, it appears that consistent condom use rates
among FSW in Myanmar increased from about 30% in 1997 to about 50% by the year 2000.
Based on an HIV prevalence estimate of about 500 000 in the year 2000, the annual number of adult AIDS
cases in Myanmar was calculated by UNAIDS to be 46 600 in the year 2000 and is projected to reach over
55 000 in 2005.
The annual number of AIDS deaths that can be expected to occur in Myanmar will be considerable.  These
deaths will constitute a major, if not the major cause of death in young adults in Myanmar during the coming
decade.
Estimated clinical
impact of HIV
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Thailand
Thailand is situated in the west of the Indo-Chinese Peninsula of south-east Asia.  Thailand shares land
borders with Cambodia, the Lao People’s Democratic Republic, Malaysia and Myanmar (Burma).  In 2000
the population of Thailand was estimated to be about 62 million, with about 36 million in the 15-49 year-old age
group.  Almost one-fifth of the population lives in urban areas.  More than one-third of the population is younger
than 15 years.
Thailand has a predominantly market economy based largely on services, light industry and agriculture. The
GNP is increasing much more rapidly than the population.  Thailand continued to have a trade deficit during
the 1980s and into the 1990s. Thailand is among the more developed countries in Asia and during the early
1990s became ineligible for some bilateral donor assistance.
Thailand was the first country in Asia to document HIV epidemics among IDU) and FSW and their clients.  After
a brief period of denial of a significant HIV epidemic, the country organized a national programme, supervised
from the highest level of Government, to respond to the HIV epidemics.  Thailand has a very comprehensive
HSS system that has provided reliable information on HIV trends in selected sentinel populations throughout
the country.
The Thai HSS system was started in 14 provinces in 1989 and expanded to all 76 provinces by 1990. The
system includes blood donors, ANC, IDU, male STI clinic patients, and FSW, both in brothels (direct) and in
massage parlors and other places (indirect).
Source: MOH Thailand
HIV/AIDS situation
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In addition to HSS data, HIV data on IDU in Thailand have been supplemented by separate IDU serosurveys.
In Bangkok, in late 1987, 1% of IDU were HIV-positive. By the end of 1988, that rate had increased to 30%.
Since 1988, HIV prevalence among IDU tested has remained between 20%-50% both in and outside
Bangkok.
HIV surveillance data in Thailand indicates that HIV prevalence peaked in FSW and their clients around the
mid-1990s and has been slowly decreasing since then (Figure 5).  As of the year 2001, about 1.85% of the
total 15-49 year-old population in Thailand are estimated to be infected with HIV.
The HIV/AIDS situation in Thailand is closely monitored and projected (modelled) for public health and health
care planning by a national expert group – the Thai Working Group on HIV/AIDS Projection (2000) and the
following summary information was provided in their most recent report.
• 984 000 people (951 000 adults and 33 000 children) have been infected with HIV in Thailand
since the start of the epidemic.
• 289 000 of these people have subsequently died of AIDS.
• 695 000 people are currently living with HIV and AIDS in the country.
• 29 000 new infections will occur this year of which 4200 will be in children
• 55 000 Thais will develop serious AIDS-related illnesses this year requiring medical care and
approximately the same number will die of AIDS complications.
These estimates indicate:
• Approximately 2% of Thai men and 1% of Thai women are living with HIV.
• Infection levels in the adult male population will remain above 1.5% until the end of 2006.
• Each year, up until the end of 2006, over 50 000 Thais will die from AIDS-related causes.
• Over 90% of these AIDS-related deaths will occur in people aged 20-44, the most productive
sector of the workforce.
• Unless prevention efforts are sustained at a high level, the epidemic could quickly regain momen-
tum and start to increase rapidly.
Although Thailand has had substantial success in HIV prevention efforts, close to 30 000 new infections
continue to  occur each year, according to Thai authorities.  At present almost three-quarters of a million people
Estimated  clinical
impact of HIV
HIV/AIDS
prevention in
Thailand
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in the Kingdom are living with HIV or AIDS, creating serious demands for care and social support.
Since it was recognized from the beginning of the HIV epidemics in Thailand that most HIV transmissions were
occurring through commercial sex, major efforts were focused on reducing the number of males visiting FSW
and promoting condom use in all commercial and casual sexual interactions. These efforts substantially
changed the levels of risk behaviour in the country:
• The percentage of adult men visiting FSW annually has fallen from almost 25% of the population to
roughly 10%, and
• Condom use when visiting sex workers has become the norm.
The Thai expert group has estimated that these behaviour changes have prevented millions of HIV infections
in Thailand during the past decade.
However, as with most other countries in Asia and throughout the world, Thailand has not had much success
in reducing HIV prevalence in their IDU population.  HIV prevalence among Thai IDUs ranged from 30%-
40% during most of the 1990s and, as of the year 2000, HIV prevalence among IDUs had increased to about
50%.
The noted “success” of Thailand with their 100% condom programme for all commercial and casual sex has
not had much effect on the slow but steady transmission of HIV from infected male clients of FSW and from
infected male IDU to their regular sex partners (wives and girlfriends).  In addition, Thailand’s HIV/AIDS
prevention interventions have suffered because of the economic crisis in Asia during the late 1990s.  The Thai
Ministry of Public Health budget for HIV decreased following the crisis in 1997 and many of the international
donors (AUSAID, USAID) who left Thailand during the economic boom years have not returned.  Thus,
overall there are currently fewer resources for HIV/AIDS prevention and treatment in Thailand than
previously.
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 Group II  – Moderate HIV prevalence countries
India
India is one of the largest countries in southern Asia – geographically it is the seventh largest and second most
populous nation in the world.  Its estimated total population in 2000 was close to one billion, with over half a
billion in the 15-49 year-old age group.  India shares land borders with Bangladesh, Bhutan, China,
Myanmar, Nepal and Pakistan.  The shift of population from rural to urban areas is slower in India than in most
developing countries, but one-fourth of the total population is now urban.
India has a developing mixed economy in which both the public and private sectors participate.  India’s
economic growth, though fairly steady since independence in 1947, has been slow, and its gross national
product (GNP) per capita remains among the lowest in the world.
HIV infections were likely imported into India in the early to mid-1980s.  The first case of AIDS in India was
detected in 1986.  Since then, HIV infections have been reported in all States and Union Territories.
With a population of one billion (about half in the 15-49 year-old population), HIV epidemics in India will have
a major impact on the overall spread of HIV in Asia and the Pacific as well as globally.  The spread of HIV within
India is – at least – as diverse as the societal patterns between its different regions, States and metropolitan
areas.  As a result, tracking HIV patterns, prevalence and trends, and implementing effective programmes,
poses a serious challenge to public health programmes.  Although HIV prevalence is low in a majority of
States, the numbers of HIV infections overall are high.  The epidemics vary from States with heterosexually
transmitted infections predominating, in Maharashtra and Tamil Nadu, to infections concentrated among
injecting drug users (IDU) and their partners in Manipur
The distribution of HIV/AIDS in India is very heterogeneous.  HIV epidemics are focused very sharply in a few
southern States, with most of India having extremely low rates of infection.  It is noteworthy that 21 of the 31
States only report 4% of the total reported national AIDS cases.  The major impact of HIV/AIDS is being felt in
Maharashtra in the west, Tamil Nadu in the south with adjacent Pondichery, and Manipur in the north-east.  All
of these findings highlight the fallacy of considering average national HIV/AIDS figures in India for measuring
the HIV/AIDS epidemics.  India clearly has areas very severely affected by HIV/AIDS, and yet, as of 2001,
major portions of the country still have a very low HIV prevalence.  Unless this differential is taken into account
for planning interventions, efforts are likely to be inadequate in some areas, and inappropriate in others.  With
a high prevalence of tuberculosis infection in India, the problem of tuberculosis related to HIV infection also
poses a major public health challenge.
Between 1994 and 1997, HIV prevalence among STI clinic attendees in Maharashtra state increased from
6% to 36%, and prevalence among IDU in Manipur increased from 25% to 61%.  However, there were
insufficient numbers of sentinel surveillance sites to get an adequate picture of the overall HIV situation.  There
was non-participation of some states, inadequate representation of various risk groups, no representation of
HIV/AIDS situation
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the rural population, and a scattered schedule of rounds of collection.  In order to obtain better HIV prevalence
for India, the National AIDS Control Organization (NACO) instituted a National HIV Sentinel Surveillance
(HSS) programme.  States were given guidelines on the selection HSS sites to adequately represent the
various population subgroups and a regularly scheduled timing for surveillance was instituted.
The 1998 HSS data from antenatal clinics in seven metropolitan cities in the country showed HIV prevalence
to be over 2% in Mumbai, more than 1% in Hyderabad and Bangalore, and below 1% in Calcutta,
Ahmedabad and Delhi.  HIV prevalence levels outside these major urban agglomerations are lower in
general, and no infection was found in a number of rural HSS sites.
Based on the analysis of existing sentinel surveillance data, the States and Union Territories can be broadly
classified into three groups.
Group I – High HIV prevalence States: includes five States – Maharashtra, Tamil Nadu, Karnataka, Andhra
Pradesh and Manipur, where HIV prevalence rates were 1% or greater in antenatal women.
Group II – Moderate HIV prevalence States: includes five States – Gujarat, Goa, Kerala, West Bengal and
Nagaland, where HIV prevalence rates were 5% or more among high HIV-risk behavior groups but below
1% in antenatal women.
Group III – Low HIV prevalence States: includes the remaining States, where HIV prevalence rates in any of
the high HIV-risk behavior groups were still less than 5%.
In late 1998,  NACO convened a group of national and international experts to review the results of the first
round of the expanded HSS with the goal of producing state-specific and national estimates on HIV/AIDS.  The
new calculations provide greater consistency in making a national estimate of HIV prevalence in India, and the
working estimate derived from this consensus meeting – 3.5 million people living with HIV and AIDS in mid-
1998 is well within the range of previous estimates. A similar estimation process was held in early 2001 and the
national prevalence estimate was increased for 2000 to 3.9 million.
Realizing the need for behavioural data, behavioural surveillance has figured as an important activity in the
AIDS II Project.  A protocol on behavioural surveillance has been finalized after intensive consultation with
sociologists and behavioural scientists.  The protocol has been provided to States and Union Terrritories for
Estimation of
national HIV
prevalence
Behavioural
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initiating this activity.
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Based on the HIV prevalence estimate of 3.9 million in 2000 in the 15-49 year-old population, and on the
estimated age and general shape of the annual HIV incidence curve, the annual numbers of AIDS cases and
deaths can be calculated.  For 2000, a total of close to  350  000 AIDS deaths in the 15-49 year-old population
is estimated, and the numbers projected for 2005 are close to 500 000.  It needs to be fully appreciated that
these numbers are national totals and these estimated deaths will be distributed according to the current HIV
prevalence that is present in the different States.
The vast majority of these estimated and projected AIDS cases/deaths will be concentrated in the current high
HIV prevalence States of Maharashtra, Tamil Nadu, Karnataka, Andhra Pradesh and Manipur.  There will be
few AIDS cases and deaths in the current low HIV prevalence States in the central and northern portions of
India.  Similarly, the distribution of paediatric AIDS cases and maternal AIDS orphans and HIV-related
tuberculosis cases will also be occurring mostly in the five southern States with the highest current HIV
prevalence rates.
Estimated clinical
impact of HIV
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Papua New Guinea
Papua New Guinea is an island country in the south west Pacific Ocean, encompassing the eastern half of the
island of New Guinea and a chain of tropical islands.  The country is bounded on the west by Indonesia’s half
of the island (Irian Jaya), on the north by the Pacific Ocean, on the east by the Pacific and the Solomon Sea,
and on the south by the Coral Sea and Torres Strait, which separates the island from Australia.  Its estimated
population in 2000 was 4.8 million, with 2.4 million in the 15-49 year-old age group.
Papua New Guinea’s ethnic composition is extremely complex. There are more than 700 ethnic entities, which
can be divided into two large groups: Papuan, comprising more than four-fifths of the total population; and
Melanesian, less than one-sixth. The rest are Polynesian, Chinese and European.  Ethnic Papuans live in the
interior and southern sections, and Melanesian peoples live in the north and east and in the outlying islands.
Papua New Guinea possesses a developing mixed economy based to a large extent on the export of mineral
and agricultural products. The GNP is growing almost as rapidly as the population. Most of the population
exists primarily in a subsistence, non-monetarized but largely self-sufficient economy
The first HIV infections in Papua New Guinea were reported in 1987, with HIV prevalence increasing
annually throughout the early 1990s. Reported cases are equally distributed among men and women, and
infection appears to be concentrated in the capital city of Port Moresby.  Prevalence remains low among blood
donors (0.015% in 1997) and pregnant women (0.37% in 1998).  The trend in the annually reported number
of AIDS cases has continued to rise more sharply each year since the mid-1990s.  Much higher levels of
infection were found in FSW (17% in Port Moresby and 3% in Lae in 1998) and among patients attending STI
clinics (7% in 1999, increasing from 3% in 1998 in Port Moresby, and from 0.7%  to 1.2% in 4 other locations
in 1997-1999). The estimated HIV prevalence in Papua New Guinea is, as of 2000, about 15 000, or 0.6 %
of the total 15-49 year-old population, and continues to increase slowly due primarily to heterosexual trans-
mission.
A wide range of social, economic and cultural factors in Papua New Guinea have led to an environment in
which sexual risk behaviors, including low levels of condom use in casual partnerships, are widespread.
There have been a few behavioral surveys carried out recently. Among sex workers, the proportion report-
ing consistent use of condoms was around 15% in Port Moresby and Lae in 1999. The mean number of
clients per sex worker was from 3-5 per week. Sexual behaviour surveys among sex workers indicate a
predominant practice of vaginal intercourse, but 30% also report anal sex. A similar proportion reports forced
sex and group sex.
STI prevalence surveys in Papua New Guinea show a high STI prevalence among both high-risk and low-
risk groups. A 15 % prevalence of gonorrhoea among Highland’s populations and 36% among sex workers
were found. Chlamydia prevalence was up to 26% in Highland’s populations, and 31% in sex workers.
Prevalence of syphilis was 4% in Highland’s populations and 32% in sex workers. Trichomoniasis was found
in 45-50% of both the low-risk and high-risk populations.
HIV/AIDS situation
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Based on an estimated HIV prevalence of about 13 800 in 1999, it was projected that there would be about
15 000 HIV infections and close to 2000 cumulative AIDS  deaths in 2000. The annual number of AIDS cases
deaths was projected to be about 750 in 2000 and close to 2400 in 2005.
Estimated clinical
impact of HIV
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Malaysia
Malaysia is unique in that it is the only country that has territory on both the mainland and insular regions of
south-east Asia.  It is composed of two noncontiguous regions – Peninsular, or West Malaysia, and East
Malaysia.  Peninsular Malaysia is bordered on the north by Thailand and on the south by Singapore.  In
2000, the total estimated population was close to 23 million, with about 12 million in the 15-49 year-old age
group.  Ethnic Malays constitute about two-thirds of Malaysia’s inhabitants.  Chinese who migrated from south-
eastern China make up about three-tenths of the population, and Indians, Pakistanis and Tamils (from Sri
Lanka) account for most of the remainder.  The population of East Malaysia is even more diverse than that of
Peninsular Malaysia. The main groups are Chinese (about one-third of the population) and some 25 ethnic
groups, as well as smaller tribal subgroups.
Peninsular Malaysia has about four-fifths of the country’s population.  Approximately two-fifths of the population
is urban and the trend of migration is toward the cities.  Malaysia has a predominantly market economy that has
been transformed from one heavily dependent on the production and export of raw materials to one that is
much more diversified. The New Economic Policy and its successors were designed to reduce poverty
among Malays and other indigenous people. The GNP per capita is, after Singapore and Brunei, the third
highest in south-east Asia.
The first AIDS case in Malaysia was reported in December 1986. Since then, the number of HIV infections
reported to the Ministry of Health has continued to rise.  Data on HIV/AIDS have been collected through
various surveillance activities such as routine surveillance, HIV sentinel surveillance (HSS), and special or ad
hoc studies.
HIV screening activities throughout the country were started in 1986 among blood donors, injecting drug
users (IDU), prisoners, delinquent girls in the rehabilitation centers, sex workers, and those suspected to be
exposed to HIV.  The Malaysian HSS system was established in 1994 among women attending antenatal
clinics (ANC), STI patients and patients with tuberculosis.  Beginning in 1998, as tuberculosis patients and
ANC attendees were included in routine HIV screening, these target sentinel groups were removed from the
HSS system.
The majority of reported AIDS cases (59.6%) and HIV-infections (76.1%) contracted their infection through
injecting drug use. A study among HIV-positive IDUs showed that all of them shared needles.  Transmission
through sexual intercourse accounted for 25.0% of the AIDS cases and 11.7% of HIV infections.
Malaysia is a country with HIV epidemics primarily among its IDU population.  HIV prevalence is still very low
in the ANC population (0.03 % in 2000, with about 285 000 women tested) and in the blood donor population
(0.024 % in 1999, with over 330 000 donors tested).  HIV prevalence rates in pockets of FSW and STI
patients in major cities are beginning to exceed 5%, but overall throughout the country, HIV prevalence rates
HIV/AIDS situation
HIV/AIDS in Asia and the Pacific Region 2001
31
   WHO
in these risk behavior groups are still probably less than 5%.
HIV prevalence among IDU groups appears to be still rising as shown in Figure 6.
A 2001 consensus workshop on HIV/AIDS estimated a total HIV prevalence of 42 000 in 2000.
Based on an estimated HIV prevalence of about 42 000 in the year 2000, the annual number of AIDS deaths
that can be expected in the year is close to 2400, and it is projected that the annual number of AIDS deaths will
be over 6000 in 2005.  The vast majority of these deaths will be in young (25-39 year-old) males.
Estimated clinical
impact of HIV
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Number of samples:
1987: 1057 1991: 8657 1995: 12 645 1999:18 895
1988:  916 1992: 15 099 1996: 26 595 2000: 19 500
1989: 1750 1993: 18 226 1997: 18 288
1990: 7901 1994: 23 544 1998: 27 150
FIGURE 6:
Percentages of IDUs
reactive for HIV by
year, Malaysia,
1987-2000
Source: MOH Malaysia
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Nepal
Nepal is a landlocked country in southern Asia, bordered on the north by Chinese Tibet and the Himalayas
and by India to the east, south and west.  As a result of its years of geographical and self-imposed isolation,
Nepal is one of the least-developed nations of the world.  The population of Nepal in 2000 was estimated to
be close to 24  million, with about 11 million in the 15-49 year-old age group.
The urban population in Nepal is mostly concentrated in the Kathmandu valley.  The Government is trying to
reduce the high population density in the Tarai region with improved transportation and communication
networks, area development projects, and the installation of small industries in rural areas to encourage the
growth of smaller urban centres.  Nepal has a market economy largely based on agriculture; external donors
have heavily subsidized economic development.  The gross national product (GNP) per capita is one of the
lowest in the world.
As with virtually all other countries in Asia, the first cases of AIDS or HIV infection, were detected during the late
1980s and early 1990s either in a foreign visitor or in a citizen who returned from international travel.  During
the early 1990s, HIV seroprevalence surveys detected HIV infections among STI patients and FSW throughout
most regions in Nepal.  As a result, there is great public health concern that extensive spread of HIV, similar
to that documented in several neighboring countries (Cambodia, Myanmar, Thailand and parts of India) might
occur.  IDU in Nepal were initially believed to share injection equipment in relatively small and isolated
networks. However, since the mid-1990s, an explosive increase in HIV infection (infecting about half of all IDU
throughout the country) has occurred.
Nepal also has a unique situation with regard to the number and mobility of FSW and young males who work
in India.  Large numbers of young Nepalese girls are recruited as FSW to Indian cities, and large numbers of
young Nepalese males working in India frequent FSW there and within Nepal.  Thus, in addition to the
increasing number of HIV infections occurring among persons with high HIV-risk behaviors in Nepal, there
are also increasing numbers of Nepalese FSW and young male Nepalese workers who have been infected
with HIV in India, and who have or will be returning to Nepal.
The estimated HIV prevalence in Nepal in 2000 was over 30 000 or close to 0.3% of the total 15-49 year-old
population.  Asian countries with the highest HIV prevalence (from 2-3% of their 15-49 year-old populations)
in the region all have brothel-based FSW as a dominant factor.  Because Nepal’s pattern of FSW is primarily
non-brothel based, it appears likely that HIV prevalence in Nepal may not reach such high levels.  Effective
public health programmes that can increase consistent condom usage levels in FSW and their male clients to
80-90% may be capable of keeping HIV prevalence in Nepal to less than 1% (i.e., less than 100 000) of the
15-49 year-old population.
HIV/AIDS
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Based on an estimated HIV prevalence of about 34 000 in 2000, the number of  AIDS deaths that can be
expected in the year 2000 is close to 3000 and this figure is projected to more than double (about 6000)
in 2005.  It is estimated that these AIDS deaths will increase total deaths in the 15-49 year-old age group
by about 5% in 2000 and account for close to 20% of total deaths in this age group in 2005.
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Viet Nam
Viet Nam, in south-east Asia, has an estimated 2000 total population of 78.7 million, with 42 million in the 15-49
year-old age group.  The country shares land boundaries in the north with China and in the west with the Lao
People’s Democratic Republic  and Cambodia.
Viet Nam has a centrally planned, developing economy that is largely based on agriculture. In 1986, Viet Nam
began to move toward an economy that utilized market forces and incentives and tolerated private enterprise.
Viet Nam’s GNP per capita remains one of the lowest in the world.
HIV/AIDS infection has been reported in all 61 provinces/cities throughout the country.  From sentinel surveillance
data collected over the past few years, it is possible to describe at least three somewhat separate HIV epidemics
in Viet Nam.  The most advanced HIV epidemic started among older male IDU in cities of south and central Viet
Nam. HIV prevalence among these men varies from 5% to over 50%. A new group of younger men in the
southern provinces, who are starting to inject heroin after beginning use by smoking or snorting it, are starting
to blend in with this older epidemic. There are also some women in the south who are beginning to inject heroin
and who are FSW.  A second and more recent HIV epidemic is among young male IDU who live along the main
heroin trafficking routes and in cities in the far north of the country  and in the Red River Delta. As of 31 May
2001, IDUs accounted for about 61% of cumulative numbers of reported HIV infections. The third HIV epidemic
is developing among women who are FSW (Figure 7) in the southern provinces, especially in the Mekong
Delta area and in the border
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impact of HIV
provinces with Cambodia. These FSW have acquired their infection in Cambodia and/or in Viet Nam close to
the Cambodian border. Sentinel surveillance data have shown an overall increasing trend of HIV infection in
sentinel  groups.
An expert national committee estimated HIV prevalence in the year 2000 to be about 122 000 (ranging from
107 000 to 137 000) for a prevalence rate of 0.29% in the 15-49 year-old population.
The first BSS started in five provinces in July 2000. The frequency of needle sharing (in the previous six
months) among injecting drug users has been found to be highest  (about 42%) in Ho Chi Minh City, an area
with high HIV prevalence among IDUs. About 30-56% of IDU report using condoms consistently with FSW
during the previous 12 months. Among FSW, the frequency of sexual contacts is around 60 times/month/SW.
Consistent use of condoms is lowest in Ho Chi Minh City (about 31% for Karaoke-based FSW and 55% for
street-based FSW). FSW in Hanoi has reported the highest rate (13%) of injecting drug during the last 12
months.
Based on an HIV prevalence of about 122 000 in 2000, and using different assumptions for the annual HIV
incidence curves for the IDU epidemic and the heterosexual epidemic, the annual number of AIDS cases was
estimated and projected using Epimodel.   Close to 4000 AIDS deaths are estimated in 2000 and the annual
total of AIDS deaths projected for 2005 is over 11 000.
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Singapore
Singapore is an island city-state situated at the southern tip of the Malay Peninsula.  A road and rail causeway
across the Johor Strait to the north connects it with Peninsular (West) Malaysia; the Strait of Malacca to the
south-west separates Singapore from the Indonesian Island of Sumatra. The estimated population in 2000
was about 4 million, with about 2 million in the 15-49 year-old age group.
The population consists predominantly of Chinese (three-fourths of the total); with Malays and Indians com-
prising most of the remainder.  The growth rate of Singapore’s population declined by more than half between
the 1960s and 1980 following the introduction of birth control measures. As a result, less than one-fourth of the
population is under 15 years of age.  Singapore’s population is virtually all urban.  Singapore has a
predominantly market economy based largely on international trade and finance. The GNP per capita, which
is growing much more rapidly than the population, is the highest in south-east Asia.
The first HIV infection was reported in Singapore in 1985.  Since then, annual reported numbers of HIV/AIDS
have increased steadily.  Up until the early 1990s, MSM (including bisexuals) comprised the majority of
reported cases of HIV/AIDS. Since then, heterosexually acquired HIV infections and AIDS cases have been
steadily predominating.  The majority of the cumulative reported AIDS cases have been among men (88%)
and heterosexuals (75%). MSM  (including bisexuals) have accounted for about  22% and IDU about 2%.
HIV seroprevalence surveys have been conducted since 1989 among STI patients, antenatal clinic attendees,
tuberculosis patients and blood donors.  Results have shown that Singapore has a low HIV prevalence. In
2000, HIV prevalence rates were about 1% among STI patients and 0.002% among blood donors.  An
overall HIV prevalence of about  3500 was estimated in 2000.
Based on data from screening of sex workers attending public STI clinics (1996), a low  prevalence of
chlamydiasis ( 0.8%) and gonorrhoeae (0.2%) was found in this high-risk population as result of intensive
education and prevention programmes.
The number of new AIDS cases estimated for the year 2001 is about 140 and the projected number for 2005
is about  220.  However, these estimates and projections may be much lower since anti-HIV treatment
provided in Singapore will delay and/or prevent the development of AIDS in many of its HIV-infected resi-
dents.
Estimated clinical
impact of HIV
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Australia
Australia covers a land area of 7 692 000 square kilometres and lies between the Pacific and Indian oceans.
The population increased from about four million in 1900 to nearly 19 million by 2000, with about 9.5 million in
the 15-49 year-old age group. Migration has been a key factor in population growth.  The population is
culturally diverse.  Almost one in four Australians were born overseas, more than half of these in a non-English
speaking country, while 40% were either born overseas or had a parent born overseas.  People of
Aboriginal and Torres Strait Island descent (although they have increased numerically in the last few decades)
number less than 2% of the Australian population (Australian Bureau of Statistics 1999).
Australia’s population enjoys good health relative to other countries, with increasing life expectancy and a low
incidence of life-threatening infectious disease. Australia’s indigenous people, however, experience much
poorer health across a range of health indicators than the rest of the population.
Australia is a prosperous country with a capitalist mixed economy.  Per capita GDP is higher than in European
Union member states (controlling for purchasing power parity).
The epidemiological pattern of HIV in Australia has been and continues to be very similar to that of countries
in North America and Western Europe.  Extensive HIV transmission occurred within MSM populations in
Australia during the early 1980s, with a peak annual incidence of close to 3000 shortly before the mid-1980s.
Since that peak, the annual number of HIV diagnoses has continued to decline substantially over time, but the
decline appears to have slowed in recent years to around 680 in 1999.  The spread of HIV among IDUs in
Australia has been and remains limited (less than 0.5%  in both men and women seen at metropolitan sexual
health centres from 1994 to 1999 who identified as IDU), due to effective prevention programmes.  Hetero-
sexual transmission of HIV also remains at low levels (HIV incidence in women having heterosexual contact
was estimated by back-projection to have increased during the late 1980s to a peak of around 80 new
infections in 1990, followed by a decline).
Transmission of HIV in Australia continues to be overwhelmingly through sexual contact between men.  Over
85% of HIV transmissions in Australia are estimated to have been via this route.  The number of diagnoses of
newly acquired HIV infection among homosexually active men has remained stable at around 130 -180
infections per year since 1993.
At the end of 1999, the cumulative number of HIV infections that had occurred in Australia was estimated to be
18 000, with an estimated 12 000 living with HIV infection.
The annual number of AIDS cases in Australia appears to have peaked in 1994, with an estimated 950 cases,
and is estimated to have declined to about 196 cases in 1999. The decline in AIDS diagnoses since 1996 has
been much more rapid than originally predicted in the mid 1990s.  It is now clear, since around 1996,  that  the
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additional decrease in the number of AIDS diagnoses is due to the use of effective combination anti-retroviral
therapy for the treatment of HIV infection. There have been similar findings in Canada, the United States and in
a number of European countries.
Assuming that the overall benefit of antiretroviral treatment in slowing progression to AIDS remains at the 1999
level, AIDS incidence is predicted to remain steady at around 190 cases per year until 2003. It is currently
estimated that around 50% of all people living with HIV infection in Australia are receiving antiretroviral treatment.
If this proportion were to increase substantially, then AIDS incidence would be expected to decline. However, the
long-term effect of anti-retroviral treatment is unknown and, if treatments fail for a substantial proportion of people,
then AIDS incidence could increase again.
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* Part of EMRO
Pakistan *
Pakistan is Asia’s seventh largest country, occupying the north-western portion of the Indian subcontinent.  It
is bounded to the west by Iran, to the north by Afghanistan, to the north-east by China, to the east and south-
east by India, and to the south by the Arabian Sea.  Almost all of the population is Muslim; Hindus and
Christians make up small minority groups.  The estimated population in 2000 was about 151 million, with 72
million in the 15-49 year-old age group.  Pakistan has a developing mixed economy based largely on
agriculture, light industry and services.  The GNP is increasing more rapidly than the population, but per
capita is still among the lowest in Asia.
Pakistan, as of 2000, had an estimated HIV prevalence level that can be considered moderate.  The vast
majority of all detected HIV infections in Pakistan have been found in IDU groups.  Low rates (generally less
than 1%) of HIV infection have been found in FSW tested as part of the HIV surveillance system.  There are
no data to indicate that  aside from IDU transmission, there is any other significant transmission of HIV occurring
in Pakistan at the present time.
UNAIDS/WHO estimated HIV prevalence in Pakistan in 1999 to be about 73 000.
Based on an estimated HIV prevalence in 1999 of 73 000, annual AIDS deaths in Pakistan are estimated at
around 3500 for 2000 and around 11000 for 2005.
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 Group III – Low HIV prevalence countries
Indonesia
Indonesia is an island republic lying off the coast of mainland south-east Asia and comprises
some 13 670 islands.  It is the fourth most populous country in the world, with an estimated
total population of about 212, about 116 million of them in the 15-49 year-old age group
in 2000.  More than four-fifths of the population are Muslim.  The densely settled island of
Java alone accounts for more than half of Indonesia’s population.  Madura, Bali and parts
of Sumatra and Celebes also have high population densities.
Indonesia has a developing, mixed economy that is based largely on agriculture and
manufacturing. The GNP is growing more rapidly than the population; the GNP per
capita, however, is low.  A marked economic recession that started after 1997 has resulted
in a devaluation of the country’s currency to about one quarter of its former value against
the US dollar.
Until the end of 1998, all HIV/AIDS data collected in Indonesia from all sources indicated
that HIV seroprevalence rates were very low (below 0.1%), even in the highest heterosexual
risk groups such as FSW.  The exception to these very low HIV prevalence was in Merauke
(in West Irian) where relatively high HIV prevalence rates were reported among FSW
HIV/AIDS situation
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Starting in 1999 and continuing in 2000, several HSS sites for FSW began to detect
increasing numbers of HIV infections, and prevalence rates of from 1-5% were found in
several areas.  Although IDU populations were not included as a routine HSS group,
several ad hoc serosurveys  throughout Indonesia, especially in Jakarta, detected sharply
increasing HIV prevalence (up to over 35% in Jakarta) among  IDUs in late 2000.  This
increasing trend of HIV prevalence can be seen in the blood donor data from the Indonesian
Red Cross from 1992 to 2000 in Figure 8.  In recent years, approximately 750 000 to close
to 1 million blood donors have been screened annually for HIV.  A marked increase was
seen in 1999/2000, probably reflecting the large increase among IDU populations noted
during the same time period.
Based on the most recent HIV prevalence findings among different HIV-risk behaviour
groups, and on estimates of the size of these risk behaviour groups, a national consensus
workshop, held in Jakarta in March 2001, estimated from 80 000 to 120 000 HIV infections
in Indonesia in the year 2000.  Indonesia is now classified as a country with a concentrated
HIV epidemic, primarily among its IDU population.
Based on an estimated HIV prevalence of about 100 000 in the year 2000, with about half
of that number occurring in 1999 and 2000, the calculated number of AIDS deaths for the
year 2000 is about 3000.  This annual number is projected to increase several times by
2005 (close to 18 000).  Most of these AIDS deaths will be occurring in or around Jakarta,
because this is where the majority of the HIV-infected IDU populations live.
Estimated clinical
impact of HIV
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China
China is the third largest country and has the largest population in the world. The total
population in 2000 was estimated to be over 1.2 billion, with about 720 million in the 15-
49 year-old age group.  China contains more than one-fifth of the world’s  population.  It
is a multinational country, with a large number of ethnic and linguistic groups. The ethnic
Chinese, however, constitute more than 90% of the population.
The gross national product per capita in 1999 was US$783.
China’s transition since 1978 from a planned economy to an open market has led to an
unprecedented period of economic growth. However, these changes have also been
accompanied by changes in social norms and HIV-risk behaviours. With a population of
over 1.2 billion, even a limited HIV epidemic in China will result in millions of infections.
As of 2001, the number of reported AIDS cases in China remains small, but all 31 provinces
have reported AIDS cases.  During the last few years, China has developed a formal HIV
surveillance system.  During 2000, 101 sentinel sites for 5 target populations (STI clinic
attendees, underground FSW, IDU, long-distance truck drivers and antenatal women)
were conducted in 31 provinces, autonomous regions and municipalities. This represents
an almost doubling of the sentinel sites that were operational in 1997.
All the available HIV/AIDS data collected to date indicate that HIV spread among IDU
populations is continuing to increase and is spreading to more provinces.  Over half of the
25 IDU sites detected HIV infection, and HIV prevalence rates ranged from 1%  to 80%
in the provinces of Yunnan, Xinjiang, Guangxi and Sichuan.
There is increasing public health concern that such high prevalence rates among IDU
groups in these provinces will ignite an extensive spread of HIV among FSW and their
clients.  Although a few HIV infections have now been detected among FSW and STI
patients in these provinces, the number of HIV infections that are not associated with
IDU in these provinces still remains low.
Thus, there are still no conclusive data to indicate that any extensive spread of HIV is
occurring among the highest heterosexual risk groups in China.  The National HIV
Surveillance System has estimated that around 90% of the cumulative number of HIV
infections in China are related to IDU and to faulty plasma collection procedures.  The
latter problem has been aggressively addressed and is now being carefully followed up, but
the IDU problem appears to be continuing almost unabated.
Some behavioural-risk assessment data have been collected from IDU and FSW groups.
These data show that the levels of specific HIV-risk behaviours continue to be very high
among these population groups.  A very large proportion of FSW report that they never
use condoms (more than 49 % in general, more than 31% in Beijing and 70% Anhui) and
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a relatively large proportion of IDU groups continues to share injection equipment (73%
in Hunan, 81%in Jiangxi and 100% in Xinjiang). In addition, the finding of high levels of
heterosexual risk behaviours in some areas of China, especially among the “mobile working
population” has to be addressed aggressively with behaviour change programmes before
HIV prevalence rates are detectable by sentinel surveillance.
One worrisome indication of the presence of such risk behaviours is the increasing number
of reported cases of sexually transmitted infection (STI) and high STI prevalence among
risk groups. Reported cases of STI have increased from 5.8 thousand in 1985 to over 836
thousand in 1999 (Figure 9).   Considering the fact that reported cases are thought to be
seriously underreported, these data suggest the increasing potential for extensive spread of
HIV. A recent study in 2000 showed that 86% of female sex workers in Kunming, Yunnan
province, and 17% of truck drivers in Tongling, Anhui province were infected with at least
one STI.
There are also other indications of increasing risk for heterosexual HIV transmission in
China.  With official estimates of more than 3 million sex workers in China, condom use
and HIV prevalence among sex worker populations are important indicators of heterosexual
risk of infection. Data from sentinel surveillance sites show that about 10% of sex workers
reported always using condoms with clients, and close to half reported never using condoms.
There are limited, but adequate HIV data to provide reasonable working estimates of
HIV prevalence in China, and the official working estimate of 600 000 in the year 2000,
developed by the Ministry of Health, appears reasonable.
China faces many challenges in the coming years in preventing rapid growth of HIV
infection. Information campaigns have been few and the level of knowledge of prevention
measures is low.  The illegal nature of injecting drug use and sex work makes populations
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FIGURE 9:
Reported STI in China,
1985-1999
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with these behaviours very difficult to reach.  Finally, China’s increasingly mobile population
will pose challenges to effective implementation of public health interventions.
Regardless of whether the overall epidemic potential for extensive heterosexual spread of HIV in China is
large or small, the only prudent public health course of action is to promote and aggressively implement a
“100% condom use programme” for all commercial and casual sex settings, and harm-reduction programmes
for injecting drug users.
Based on the HIV prevalence estimate of 600 000 in 2000 in the 15-49 year-old population, and on the
general shape of the annual HIV incidence curve as well as other assumptions, the annual numbers of AIDS
deaths was estimated.
For the year 2000 a total of about 20 000 AIDS deaths in the total 15-49 year-old population is estimated and
the numbers projected for 2005 are about 3-5 times greater – about 60 000-100 000.  It needs to be fully
appreciated that these numbers represent a national total and will be distributed according to the current HIV
prevalence that is present in the different provinces.  The vast majority of these estimated and projected AIDS
cases/deaths will be concentrated in the current high HIV prevalence provinces of Yunnan, Xinjiang, Guangxi
and Sichuan. There will be few AIDS cases and deaths in most other provinces, where HIV prevalence is
currently low.  Similarly, the distribution of paediatric AIDS cases and maternal AIDS orphans and HIV-related
tuberculosis cases will be occurring mostly in the provinces with the current highest HIV prevalence rates.
Estimated clinical
impact of HIV
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Hong Kong, China
In July 1997, Hong Kong became a special administrative region of China on the southern
coast of China.  It comprises the island of Hong Kong and adjacent islets and the Kowloon
Peninsula on the mainland of China, as well as the New Territories.  About 95% of the
people of Hong Kong are Chinese. Hong Kong has one of the highest population densities
in the world, averaging some 6310 persons per km2 (excludes marine population and area
of reservoirs). Its population was estimated to be about 7000, with close to 4000 15-49
year-old age group in 2000. Virtually all Hong Kong’s people live in urban areas.  Hong
Kong has a market economy based largely on finance and thriving international trade.  Its
economy has experienced generally steady growth since the mid-20th  century.  The per
capita income is now one of the highest in Asia.
In Hong Kong, the first HIV infection was reported in 1984 and the first case of AIDS in
1985.  Since then, numbers of reported cases have been growing steadily.  At the end of
2000, the cumulative reported number of HIV infections was 1542, of which 500 had
progressed to AIDS.  The majority of the initial HIV/AIDS cases identified in Hong Kong
were in MSM and male haemophilia patients.  There are no data to suggest that any
significant self-sustaining heterosexual spread of HIV is present in Hong Kong.  The
majority of HIV infections detected among heterosexuals during the 1990s were either
acquired outside Hong Kong or were non-Chinese Asians or their contacts in Hong Kong.
Small pockets of IDU groups have been identified in Hong Kong, but to date no extensive
HIV transmission has occurred among these groups.  Several surveys in Hong Kong have
shown that HIV prevalence among pregnant women is about one in every 4000.
The current behavioural surveillance system collects data from existing surveys and specifically
designed surveys. On average, the rate of needle sharing among street addicts has been less
than 20 % in the last few years. About 80%-90% of those attending Government Social
Hygiene Clinics report visiting sex workers. About 50% of adult men attending Social
Hygiene Clinics in 1999 reported using a condom for their last sex with sex workers.
Hong Kong has been able to provide highly active antiretroviral therapy (HAART) to
HIV-infected residents since the mid-1990s.The number of HIV-infected persons who
would have developed AIDS has been reduced in recent years as a result of their access to
effective treatment.  However, a significant proportion of the estimated 2-3 thousand
HIV-infected persons in Hong Kong have not yet been identified, and many HIV-infected
persons are first detected after the onset of AIDS defining conditions.  The number of
newly reported AIDS cases in Hong Kong has stabilized at about 45 to 75 cases per year
since the mid-1990s.
Estimated clinical
impact of HIV
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Macao, China
Macao became a special administrative region of China as of December 1999.  It is located
on the southern coast of China to the west  of the Pearl River Delta .  It comprises the
peninsula of Macao and the two islands of Taipa and Coloane, with a total land area of 23.8
km2.  As of 31 December 2000, Macao’s local population  numbered 438 000 inhabitants.
Population density is over 18 000/km2,, with the northern part of the peninsula of Macao
considered one of the most densely populated areas in the world.  Macao’s economy has
been experiencing rapid growth since the 1980s.  Public health care in Macao is comparable
with that of developed countries.  The average life span for both sexes is over 75 years old.
In Macao, the first HIV infection was reported in 1986 and the first case of AIDS in 1989.
The Department of Health of Macao has, since 1986,  been conducting several surveillance
activities. The different approaches used include, among others: an unlinked and anonymous
serosurveillance  that includes  outpatients more than 15 years old and pregnant women
attending antenatal consultations as target populations;  and HIV screening for selected
groups, such as blood donors, tuberculosis patients, prisoners, injecting drug users (IDU)
referred by NGOs, and entertainment workers. Since 1986 until the end of December
2000, 230 HIV infections had been reported, 70.9% diagnosed in temporary residents
working in the entertainment industry.  The HIV transmission in Macao is essentially
sexual: the most important route of transmission has been heterosexual (71.7%).  A large
proportion of HIV cases have been found among women, transmitted through heterosexual
contact, representing 67.8% of all new cases (female to male ratio: 2.1 to 1).  If the
temporary residents working in the entertainment industry are excluded from the data, the
cumulative number of HIV cases from 1986 until the end of December 2000 is 67, and the
pattern profile of HIV infection in Macao becomes different: men are responsible for
68.7% of all new HIV cases (male to female ratio: 2.3 to 1) and for 81.0% of AIDS cases;
the principal route of transmission is heterosexual, with a percentage of 35.8%; injecting
drug use transmission accounts for 14.9% of infections;  and the homosexual route for
13.4%.  Among the 67 HIV cases detected in the Macao resident population, 21 (31.3%)
have progressed to AIDS. No estimation of HIV/AIDS was developed for Macao.
The data obtained show that the HIV spread among Macao’s general population has been
very limited, despite the tendency for increase among some high -risk behaviour groups,
such as IDUs. Surveillance of antenatal clinic attendees in Macao, has shown that HIV
prevalence is still low in that group.
Since the mid-1990s, Macao has been able to provide treatment to HIV-infected residents.
However, many of HIV-infected persons have been first detected after the onset of AIDS
defining conditions.  The number of newly reported AIDS cases in Macao has been, since
the mid-1990s, about 2 to 4 per year.
HIV/AIDS situation
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Sri Lanka
Sri Lanka is an island country in the Indian Ocean, separated from the south-eastern coast
of peninsular India.  Its estimated population in 2000 was about 19.2 million, with about
10.3 million in the 15-49 year-old age group.  The Sinhalese are the predominant ethnic
group, constituting about three-quarters of the population. Other ethnic groups include
the Tamils and the Muslims.
Sri Lanka has a developing mixed (public and private) economy, largely based on agriculture,
services and light industry.  The creation of new jobs has not kept pace with the growth of
the population, and unemployment is widespread.  The GNP is growing faster than the
population; the GNP per capita, however, is very low by world standards.
The available HIV/AIDS data for Sri Lanka indicate that extensive spread of HIV had not
occurred as of the year 2001.  HIV testing among antenatal clinic attendees was conducted
in the capital, Colombo, in 1990, 1993, 1995 and 1996. No evidence of HIV infection
was detected. Outside Colombo, HIV testing of ANC women took place in various sites,
including Anuradhapura, Badulla, Galle, Kandy, Kurunegala and Ratnapura, at various
times between 1990 and 1996.  As in Colombo, no evidence of HIV infection was found
among the antenatal clinic women tested at that time.  Among sex workers tested in
Colombo from 1990 through 1998, evidence of HIV infection was found in only one site,
in 1993, where 0.2% of the sex workers tested were HIV-positive. Outside Colombo, sex
workers were tested for HIV infection in Kandy, Anuradhapura, Galle, Kurunegala,
Ratnapura and Badulla between 1993 and 1998. Evidence of HIV infection was found in
only one site, Kurunegala, and only in 1995, where 0.5% of sex workers tested were HIV-
positive.
The best estimate of HIV prevalence in Sri Lanka, as of the year 2001, is about 8500.
There are insufficient studies and data on the patterns and prevalence of HIV risk behaviours
in Sri Lanka to suggest that the potential for epidemic or more extensive spread of HIV is
very low.  More systematic sentinel HIV surveillance needs to be developed, with primary
emphasis on high-risk groups.  In addition, baseline behavioural surveillance studies/surveys
need to be implemented as soon as possible.  Support for HIV/AIDS/STD programmes
needs to be expanded and focused on high-risk groups.
Based on an estimated HIV prevalence of 8500 in the year 2000, the number of AIDS
deaths in 2000 is calculated to be about 350 and it is projected that this number will
gradually increase to over 1000 in 2005.
HIV/AIDS situation
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New Zealand
New Zealand is an island nation in the South Pacific, lying about 1000 miles south-east of
Australia.  New Zealand has two main islands, the North and South, separated by the 20-
mile wide Cook Strait, and a number of small islands.  The estimated population in 2000
was about 3.8 million, with close to 2 million in the 15-49 year-old age group.
The principal ethnic element of New Zealand’s population (about 78%) is of European
origin (mostly British); 15% are Maori and 6% Pacific islanders.  The proportion of
people of Asian descent is projected to rise to 8% of the population by 2016.  Five-sixths of
the population lives in urban areas, and most migration within the country takes place
between urban areas.
New Zealand has a developed market economy largely based on agriculture, small-scale
industries, and services. Economic growth has been kept low by dependence on imported
fuels and capital and consumer goods. The GNP per capita is within the range of the
developed countries of the world.
The first reported AIDS cases in New Zealand were identified in 1983. The annual number
of new HIV infections has remained steady at an average of about 80-90 per year, showing
a growing pool of HIV cases. The number of current HIV infections was estimated to be
1200 in 2000. However, due to the availability of antiretroviral drugs, fewer persons with
HIV infection are developing AIDS, and those with AIDS are living longer. The number
of newly reported AIDS cases has been lower than 50 per year in recent years. According
to the New Zealand AIDS Epidemic Group, 50% of the 165 people reported to have
AIDS since 1996 were still alive in 2000.
Whilst 80% of total AIDS notifications to date are amongst men who have sex with men,
the proportion infected through heterosexual contact has increased and accounted for 18.5%
of AIDS notifications and 42% of reported HIV infections in 2000.  People infected
through heterosexual transmission are predominantly from countries with high rates of
heterosexual transmission. Less than one-third of the newly detected HIV infections in
2000 occurred in New Zealand. Data from seroprevalence surveys (1996-1997) show an
HIV prevalence of 3 % in MSM, 0.3% in IDU and 0.09% in female heterosexuals.
The confirmed number of new AIDS cases in 2000 was 27. It is projected that the number
will be similar in 2005.
HIV/AIDS situation
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The Maldives
The Maldives is a small independent island nation consisting of a chain of about 1300 small
coral islands and sandbanks (roughly 202 of which are inhabited), grouped in clusters, or
atolls, in the Indian Ocean.  The Maldivians are a mixed people, speaking an Indo-Euro-
pean language called Divehi.  With the exception of those living in the capital Male’, the
only relatively large settlement in the Maldives, the inhabitants of the Maldives live in
villages on small islands in scattered atolls. About 50 of the islands have more than 1000
inhabitants and the southern islands are more densely populated than the northern ones. Its
population was estimated to be about 269 000  in 2000.
The Maldives  has a developing economy based on tourism and fishing. The GNP per
capita is among the lowest in the world.  Tourism is a fast-growing sector of the economy.
Resort islands and modern hotels in Male’ attract increasing numbers of tourists during the
winter months.
As of mid-2001, a total of eleven HIV infections and five AIDS cases had been detected in
the Maldives and virtually all of these cases had likely acquired their infection outside the
country.  It was estimated that by the year 2000, there were less than 100 HIV infections
in Maldives.
HIV/AIDS situation
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The Lao People’s Democratic Republic
The Lao People’s Democratic Republic is a landlocked country in the centre of the Indo-
Chinese peninsula of south-east Asia.  Its total population in 2000 was estimated to be
about 5.2 million, with 2.4 million in the 15-49 year-old age group.  Cambodia, China,
Myanmar, Thailand and Viet Nam surround the country. The Lao People’s Democratic
Republic has a slowly developing, largely centrally planned economy based mainly on
agriculture and international aid. The GNP per capita in 1999 was one of the lowest in the
world.  Since 1986, the country has been moving towards a free market economy and is
increasingly opening its borders to foreign investments and visitors.
The first HIV infection in the Lao People’s Democratic Republic was identified in 1990
in a returning Lao female who was suspected to be a FSW.  The first AIDS case was
reported in 1992 in a person with a history of frequent travel to Bokeo, a province adjacent
to Chiang rai, a northern Thai province.  From 1990 to December 2000, a total of about
61 130 persons were screened/tested for HIV infection and 717 were found to be positive,
with 190 AIDS cases reported, including 72 deaths.  The majority of the identified HIV
infections were in persons with clinical illnesses and who were suspected of having acquired
their infection outside of the country via heterosexual intercourse.
IDU is believed to be very low or non-existent, but no studies have been conducted to
confirm this impression.  Data from the national blood centre confirm that HIV prevalence
is very low – of over 8000 blood donors tested in 1997 (about 5000 from Vientiane), only
one HIV-positive was found. Even although the available data are limited and may be very
unrepresentative, collectively they indicate that HIV prevalence in the Lao People’s
Democratic Republic is currently still very low.
The results of the first complete HIV sentinel surveillance round in the Lao People’s
Democratic Republic, carried out in 2000, were reported in early 2001.  More than 800
“service women”, who are considered indirect sex workers, were tested in three sites.  In
the capital city of Vientiane, about 1% of the almost 300 service women were found to be
HIV-positive and in Savannakhet, the same rate of HIV-positivity was observed among
the same number of service women tested.  Overall, less than 1% of these indirect sex
workers were found to be HIV-positive.  No details were provided as to whether these
infected females may have acquired their HIV infection in or outside the country.
In the past few years, the Lao People’s Democratic Republic has witnessed a massive
expansion in economic activity, resulting in significant increases in domestic and cross-
border population movement. The number of sex workers has also been increasing.
Community-based surveys on condom use of PSI in Vientiane in 1999 showed that, among
those who had had more than three sexual partners over the previous 12 months, 38 % had
never used condoms. The Lao People’s Democratic Republic initiated the behavioural
surveillance survey among specific subpopulations in mid June 2000. The data showed
HIV/AIDS situation
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that 73 % of service women had consistenly used condoms with clients in the previous month. Of the service
women who had had commercial sex in the past year, almost all (95.5%) reported having had only one client
on the last day worked (mean number: 1.1). Between one quarter and one third of truck drivers and police
reported “had had sex with a commercial partner in the last 12 months”. About two thirds of the police and
military, and three quarters of truck drivers  said they always used condoms with a paid partner.
National STD surveillance was established in mid 1999. Studies indicated a 12% rate of chlamydiosis among
100 antenatal clinic attendees in 1997. Data from the Lao Red Cross blood transfusion service on the
prevalence of syphilis markers showed  3% to be positive (out of 4824 tests) in 1999.  A combined HIV Sero-
sentinel Surveillance and STD Prevalence Survey was implemented in early 2001 among vulnerable
groups such as female service women, female factory workers and long distance truck  drivers. The results
are not yet available.
HIV prevalence in the Lao People’s democratic Republic was estimated, as of the year 2000, to be 1300, or
0.05% of the 15-49 year-old population (UNAIDS/WHO working group).  Based on this HIV prevalence, the
clinical case load of AIDS and other HIV-related diseases and conditions are estimated and projected to be
relatively small – ranging from less than 100 annual AIDS deaths in the year 2000 to over 200 in 2005.
STI data
Estimated clinical
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HIV/AIDS situation
Year 1996 1997 1998 1999 2000
N. pos./N. tested 2/3069 4/3028 5/2672 2/3002 4/3000
HIV prevalence 0.07% 0.13% 0.19% 0.07% 0.13%
Data source: DPH Philippines
Table 4: HIV Prevalence rates found among RFSW in HSS rounds – 1996-2000
The Philippines
The Philippines is an archipelago of about 7100 islands and islets lying about 500 miles off the south-eastern
coast of Asia. The population in 2000 was estimated to be over 80 million, with about 38.5 million in the 15-49
year-old age group.  More than four-fifths of the population is Roman Catholic, and a sizable minority is
Muslim.  Population density in the Philippines is relatively high. Nearly two-fifths are younger than 15 years of
age.  Heavy migration from rural to urban areas has caused overcrowding, particularly in metropolitan
Manila. About two-fifths of the country’s population is urban.
The economy of the Philippines is based largely on agriculture, light industry, and services.  A market
economy predominates, although intervention by the Government increased in the late 20th  century.  Prices
have tended to rise more rapidly than purchasing power, and wages are among the lowest in east Asia. The
GNP per capita, which has a negative real growth rate, is similar to that of other developing countries.
An HSS system  was developed during the early 1990s that included high behavioural risk groups in several
major urban areas.  The findings from this surveillance system indicated that HIV prevalence was very low,
since only an occasional and sporadic HIV infection was found among registered female sex workers
(RFSW) who were included in the surveillance sampling scheme (Table 4).
In 1999, the Philippine Red Cross tested 500 000 bags of blood and found only one confirmed HIV-positive
sample.  No significant transmission of HIV has yet been detected in the Philippines and, as a result, the official
national HIV prevalence estimate has been reduced from an initial 50 000 to 26 000, and most recently to
about 10 000 (range: 5000-13 000).
All of the collective HIV/AIDS surveillance data in the Philippines support the basic conclusion that extensive
transmission of HIV has not occurred, even within the highest HIV-risk behaviour groups such as MSM, IDU
and FSW.  This low and slow increase of HIV prevalence in the Philippines is due to the low infection rate of
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HIV via sexual intercourse and the generally lower prevalence of HIV-risk behaviours present in the Philip-
pines compared with those Asian countries where extensive transmission of HIV has been documented.
Early recognition of the epidemic, mobilization of relevant sectors and partners, and implementation of targeted
intervention programmes have contributed to keeping the epidemic low and slow in the country.
A behavioural surveillance survey was conducted from 1997. There was no significant change in the trend for
condom use during the last sex with a non-regular partner among registered sex workers (from 64% in 1997
to 65% in 2000). As a result of outreach interventions, the rate among freelance sex workers increased from
55% in 1997 to 67% in 2000. Sex workers have on average a low number of clients (2.2-3.5 per week,
1999). A recent study indicated that 13% of men had two or more sex partners. The percentage of IDUs who
share needles decreased from 77% in 1997 to 52 % in 2000.
Serological testing of syphilis has been incorporated into the HSS since 1993. STI prevalence surveys with
different laboratory methods have been conducted since 1991. Recent surveys show that the prevalence of
chlamydiosis is  high among sex workers, ranging from 27% to 36%. The syphilis rate in this group was of
<1% to 5 %. The gonorrhoea rate varied from 2.6% to 25%. A high level of STIs are also found among low-
risk groups. For example, Chlamydiosis was found in 7.5% to 18% of antenatal women in STI surveys in
1998.
Based on an estimated HIV prevalence of 5000 (range 5000-13 000) in the year 2000, the estimated number
of AIDS deaths in the year 2000 is about 200. In 2005 the estimated annual number is expected to range from
500-1000.
Risk behaviours
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Bangladesh
Bangladesh is a relatively small coastal country in south central Asia.  To the south, Bangladesh has an
irregular coastline fronting the Bay of Bengal and shares land borders with India and Myanmar.  Its estimated
total population in 2000 was about 128 million, with 68 million in the 15-49 year-old age group.
Bangladesh is one of the most densely populated countries in the world, with the highest densities occurring
in and around the capital city of Dhaka.  It is also a predominantly rural country, with only about one-quarter
of the population living in urban areas. Rural areas are often so thickly settled that it is difficult to distinguish any
well-defined pattern of individual villages. Bangladesh has a high rate of population growth, and almost one-
half of the population is under 15 years of age. Both birth and death rates are far above world averages.
Bangladesh has a developing mixed economy that is heavily based upon agriculture. Almost two-fifths of the
GDP originates from agriculture, followed by services, and transportation and communication. Although the
GNP is growing somewhat more rapidly than the population, the GNP per capita is among the lowest in the
world.  Severe overcrowding, an inadequate food supply and poor sanitary conditions have combined to
create extremely poor health conditions in Bangladesh.
As with virtually all countries in Asia, the first cases of AIDS or HIV infection in Bangladesh, detected during the
late 1980s and early 1990s, were either in foreign visitors or in citizens who returned from international travel.
All of the known HIV-risk behaviours and factors – FSW, MSM, IDU and “high” rates of STI – are acknowl-
edged to be present in Bangladesh.  As a result, there is increasing concern that marked epidemic spread of
HIV might occur in a manner similar to that documented in several neighbouring countries (parts of India,
Myanmar and Thailand).
Scant data are available to provide accurate definitions of the distributions or to quantify the prevalence of
these risk behaviours and factors in Bangladesh.  Although the number of heroin addicts is estimated to be
about 100 000, it appears that the majority of heroin users smoke rather than inject the drug.  Almost no data
are available to estimate the distribution and number MSM, but it is acknowledged that they exist in Bangla-
desh.
FSW are present throughout Bangladesh; prostitution areas and brothels are known, but estimates of the
number of prostitutes vary widely.  In addition, it is known that “floating” prostitutes are present in “large”
numbers, but their precise distribution and prevalence are not well known.  It is suspected that “large”
numbers of young and mostly single female textile and garment workers may also supplement their low wages
by occasional prostitution.
In 1998-1999, national sentinel surveillance surveys for HIV and syphilis infections were carried out. In
addition, behavioural surveys among selected high-risk “groups” – brothel-based FSW, STI patients, truckers
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and IDU – were also conducted.  HIV infection in the highest HIV-risk behaviour groups continues to be low.
About 2-3% of IDU and less than 1% of FSW were found to be infected with HIV.  As of mid-1999, a cumulative
total of about 100 HIV-infected persons and a dozen AIDS cases have been identified in Bangladesh.  Based
on the limited data and on the findings of the national HSS surveys, the estimate of the number of HIV infections
in Bangladesh made by WHO/UNAIDS for the year 2000 (about 13 000) appears reasonable.
Based on the HIV prevalence estimate of about 13 000 in 2000, it has been calculated that the annual number
of adult AIDS cases in Bangladesh was 1100 in 2000 and will be about 1700 in 2005.
Estimated clinical
impact of HIV
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Japan
Japan is an industrialized island country lying off the east coast of Asia.  Its estimated population in 2000 was
close to 127 million, with 58 million in the 15-49 year-old age group.
Japan has a prosperous and well-developed economy largely based on manufacturing and services. A
market economy predominates, although the Government exercises effective administrative guidance in the
private sector.  Japan’s GNP per capita is among the highest in the world.
HIV prevalence rates in Japan continue to remain well below 1% for most HIV-risk behaviour groups, except
among female sex workers of foreign nationality (2.7% from 1987-1999).  Most reported HIV/AIDS cases in
Japan during the mid-to-late 1980s and early 1990s were due to HIV-infected blood products that were
imported for the treatment of haemophilia patients.  A third of the AIDS cases (33.3%) reported in 1998 were
in those haemophilia patients who were infected through imported blood coagulation factor products.
The high percentage of haemophilia AIDS cases is still the distinctive characteristic of HIV infection in Japan
and is not seen in other countries in the world.  However, in 2000, about 78% of newly diagnosed HIV
infections appear to have been acquired through sexual contact.  One of the characteristics  in recent years
is that the infection through sexual contacts in Japan is getting higher among Japanese men. Almost all HIV
infections in Japan are related to imported infections (including the haemophilia infections) and then some
limited transmission from these infected persons to their regular sex partners.  Behavioural data show low
condom use, both in the general population and among FSW (6% to 25%).
The Ministry of Health and Welfare Panel revised estimates and projections of HIV in Japan in 1999.  Their
estimates suggest that, by the end of 1998, 8000 persons were living with HIV (prevalence of <0.01% in
people aged 15-49 years).
The epidemiology of HIV infection in Japan is unique in that several thousand infections of male haemophilia
patients occurred within a few years during the early to mid-1980s.  Aside from this initial epidemic, HIV
transmission has been minimal and mostly limited to imported infections and some limited transmission from the
several thousand HIV infections that were present in Japan since the mid-1980s.  Based on this pattern of HIV
infection and an estimated HIV prevalence of about 8000 in 1998, the annual number of AIDS deaths in Japan
in the year 2000 can be calculated to be about 600-700.  A similar annual number of AIDS deaths can be
projected for 2005.  These estimated/projected numbers may be much lower, depending on the extent to
which effective anti-HIV treatment is provided in Japan.
HIV/AIDS situation
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The Republic of Korea
The Republic of Korea is located in the southern Korean peninsula in east Asia.  Its estimated population in
2000 was about 52 7 million, with about 22.7 million in the 15-49 year-old age group. The Republic of Korea
has a predominantly market economy based largely on services and light and heavy industries.  Economic
growth has been heavily dependent on exports of manufactures.  The GNP is growing much faster than the
population.  The GNP per capita is similar to those of the other rapidly developing east Asian countries and
was ranked in the top 10 countries in Asia in 2000.
The first case of HIV infection in the Republic of Korea was reported in 1985 and the first AIDS case in 1987.
An estimated 3800 HIV-infected individuals were living in the country in 2000 (prevalence of less than 0.1%
among people aged 15 to 49 years).  The great majority (93%) of HIV infections are estimated to be sexually
transmitted, with 13% occurring among women.  National seroprevalence surveys have identified only
sporadic HIV infection.
Based on an estimated HIV prevalence of about 3800 in the year 2000, the annual number of AIDS deaths
is calculated to be between 200-300 in 2000 and is projected to increase to between 300-400 in 2005.  The
annual numbers of HIV-related tuberculosis and of paediatric AIDS cases and AIDS-related orphans will be
less than the estimated annual numbers of adult AIDS deaths.
HIV/AIDS situation
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Democratic People’s Republic of Korea
The Democratic People’s Republic of Korea occupyies the northern half of the Korean peninsula in east Asia.
Its population was estimated in 2000 to be about 23.7 million, with about 13.3 million in the 15-49 year-old age
group. The Democratic People’s Republic of Korea  has a command (centrally planned) economy based
largely on heavy industries and agriculture.  The GNP per capita remains low by world standards.
Scant HIV/AIDS data are available from The Democratic People’s Republic of Korea. It is estimated that as of
the year 2000, that there were fewer than 100 HIV infections in the country.
HIV/AIDS situation
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Mongolia
Mongolia is a landlocked country, located between Russia to the north and China to the south, in north central
Asia. It is Asia’s seventh largest country in area but one of its smallest in population.  Its estimated population
in 2000 was about 2.5 million, with about 1.4 million in the 15-49 year-old age group.
Almost four-fifths of the populace are Khalkha-speaking Mongols. The remainder consists of other Mongols,
Kazaks, Russians and some Chinese. People are encouraged by the Government to migrate from rural to
urban areas, and about three-fifths of the total population is now urban.  Until 1990, Mongolia had a socialist
centrally planned economy on the Soviet model. Thereafter, democratic reforms (including a new constitution
in 1992) began the country’s conversion to a market economy.
Mongolia has remained nearly free from HIV over the past two decades, as evidenced by the fact that only
three HIV/AIDS cases have been reported as of July  2001. The first HIV infection in the country was reported
in 1992 in a male homosexual who acquired his infection abroad and died in 1999.  The second case was
detected through screening of FSW in December 1997. The third case was diagnosed as AIDS case in a
woman at the National Center of Communicable Diseases. HIV surveillance activities and testing started in
1987, with an average of 50 000 - 70 000 tests being conducted annually.  HIV testing has since been done
annually for blood donors, high-risk groups (e.g., STI clinic attendees, FSW, homosexuals) and voluntary
clients.  In 1998, only 1 of 101 FSW tested was HIV-positive.  No other positive tests were detected in other
sentinel surveillance populations. It is estimated that, in the year 2000, there were fewer than 100 HIV
infections in Mongolia.  No other estimates or projections for HIV/AIDS in Mongolia have been developed.
HIV/AIDS situation
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Bhutan
The Kingdom of Bhutan is a sovereign kingdom in the Himalayas, bounded by India and Tibet, China.
Bhutan’s rugged mountains and dense forests long rendered it inaccessible to the outside world until well into
the 20th  century.  The building of a road network connecting Bhutan with India in the 1960s finally brought to
an end Bhutan’s historic isolation. From that time on, Bhutan embarked on a programme to build roads and
hospitals and to create a system of secular education. Its governmental institutions were also modernized.  The
Bhutanese economy is mainly agrarian; most of the population is engaged in agriculture and livestock raising.
The first case of HIV/AIDS in Bhutan was reported in 1993.  Although the first HIV/AIDS was diagnosed in the
country in 1993, the testing of army recruits that year did not find any infection in this population group.
As of  April 2001,  22 persons have been diagnosed with HIV infection, out of which 4 have died.  Recent
trends show an increase in the number of people diagnosed with HIV/AIDS and as a result, the government
has redoubled its efforts for preventing HIV and it’s implications  to the Bhutanese population. The issue is
considered important because the incidence of STI have been quite significant in the past.  The current
number of HIV estimates is about 100 in 2000.
HIV/AIDS situation
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Brunei Darussalam
Brunei is an independent Islamic sultanate occupying an enclave on the north-western coast of the island of
Borneo. The estimated population in 2000 was 321 000, with 178 000 in the 15-49 year-old age group.
Brunei has a mixture of south-east Asian ethnic groups.  About two-thirds of the population is Malay, nearly
one-fifth is Chinese, and the remainder are indigenous peoples and Indians.  Almost two-thirds of the people
are Muslims, 12% are Buddhists, 9% are Christians and, in the remote interior, there are a few animists.
Approximately two-thirds of the population is urban.
Brunei has a developing market economy based on the exploitation of petroleum and natural gas reserves.
A relatively small population combined with extremely rapid economic growth, particularly during the 1970s,
has allowed the state to give its citizens one of the highest per capita incomes in Asia.
The first HIV infection in Brunei was identified in 1986. The majority of reported infections have occurred
among immigrant workers, mostly men and heterosexuals. By the end of August 2000, a cumulative total of
521 HIV infections and only 16 AIDS cases had been reported. There are very few data on STI (reported
seroprevalence of syphilis was low 0.1-1.3% during the period 1997-1998) and no data available on risk
behaviours.
The cumulative number of long-term residents reported as HIV cases remains very low (less than 20 up to
1999). It is estimated that as of the year 2000, there were less than 100 HIV infections in Brunei.
Since the estimated prevalence of HIV in Brunei is less than 100, the estimated number of AIDS deaths in the
year 2000 and 2005 cannot be expected to be more than about five to six in each of these years.
HIV/AIDS situation
Estimated clinical
impact of HIV
HIV/AIDS in Asia and the Pacific Region 2001
63
   WHO
South Pacific island countries and territories
HIV/AIDS data from 20 Pacific Island countries and territories have been collected and analysed by the WHO
regional office in Manila.  These countries and territories included American Samoa, Cook Islands, Fiji, French
Polynesia, Guam, Kiribati, the Marshall Islands, the Federated States of Micronesia, Nauru, New Caledonia,
Niue, the Commonwealth of the Northern Mariana Islands, Palau, Samoa, Solomon Islands, Tokelau, Tonga,
Tuvalu, Vanuatu, and Wallis and Futuna. The estimated population of these countries in 2000 was about 2.8
million, with about 1.3  million in the 15-49 year-old age group.
Only sporadic HIV/AIDS cases have been reported from throughout the South Pacific, which suggests that
HIV seroprevalence remains low in this region.  As of early 2000, over 600 HIV infections (including more
than 200 AIDS cases) had been reported to the WHO Regional Office for Western Pacific.  Three territories
(French Polynesia, Guam and New Caledonia) have accounted for 80% of reported HIV infections and over
80% of AIDS cases.  Five countries/territories (American Samoa, Cook Islands, Niue, Tokelau, and Vanuatu)
have not as yet reported any HIV infections.  The majority of reported cases have occurred among men, with
sexual contact with other men being the most frequently reported mode of transmission.  However, the
proportion of heterosexual cases has been increasing over the last few years.
Few HIV seroprevalence studies have been conducted in the South Pacific.  Limited data have been collected
in some countries among populations of blood donors, pregnant women, STI clinic patients and immigrant
groups.  Most of these studies have identified few, if any HIV infections.  However, the sample sizes were small
and these findings should be interpreted with caution.  It appears from the limited HIV/AIDS data available that
most of the HIV infections in the South Pacific are imported and that there are, as of 2001, no data to suggest
that any significant or sustained HIV transmission is occurring in these island countries and territories. The HIV
prevalence was estimated, as of the year 2000, to be <0.1% of the 15-49 year-old population of these
countries.
Surveys conducted in some countries and territories show that curable STI are common. In 2000, studies of
women attending antenatal care in Samoa and Vanuatu showed that one in three women had an STI.  The
highest rates of infection (up to 50%) were found in women below 25 years of age. HIV/AIDS programmes
in the South Pacific will need to continue to focus on prevention and control of treatable STI, such as syphilis
and gonorrhoea and to develop some HIV surveillance among persons with the highest prevalence of sexual
risk behaviours.
HIV/AIDS situation
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Annex 1
Natural history of HIV infection
AIDS (acquired immunodeficiency syndrome) is a severe disease syndrome that represents the late clinical stage
of infection with HIV (human immunodeficiency virus).  The syndrome was first recognized in 1981, but
probably existed at a low endemic level in Central Africa before epidemic HIV spread began to occur in several
areas of the world during the 1970s.
Progression from asymptomatic HIV infection to clinical illness and AIDS
Initial infection with HIV is indicated by the presence of HIV-specific antibodies, often without any other signs
or symptoms. A substantial minority of infected persons, however, experience a short, mononucleosis-like illness
about 2-5 weeks after infection.  During this acute phase of infection, there may be a significant depression of the
cellular immune system and infected persons at this early stage are considered extremely infectious.  Subsequently,
the immune system rebounds to generally normal levels and the infected person becomes asymptomatic for periods
ranging from many months to many years.
HIV infection attacks the cellular immune system.  Continued damage to the immune system eventually makes
HIV-infected individuals susceptible to various opportunistic infections and cancers.  Initial illnesses related to the
increasing immune deficiency caused by HIV are generally mild to moderate in severity, and tend to be nonspecific.
These illnesses have been designated AIDS-related-complex, or ARC, but there has never been a universally
accepted definition of ARC.  The first infections described in patients with AIDS were due to ubiquitous organisms
that do not usually cause disease in healthy persons; the cancers that developed in AIDS patients were of types that
had been diagnosed only rarely in the past.  Subsequently, it became clear that persons with HIV infection could
contract almost any common or uncommon infectious disease, or some malignancies, because of their immune
deficiency.  The diagnosis of AIDS is complex and often difficult because of the many conditions that are considered
necessary to meet different surveillance definitions of the syndrome.
The time period for progression from HIV infection to symptomatic disease is highly variable: symptoms may
occur within a year, although rarely, or may take more than 10 years to appear.  Over a variable time period from
many months to many years, infected persons begin to develop clinical disease related to progressively increasing
immune deficiency.  Early symptoms may include swollen lymph nodes, night sweats, fever, diarrhoea, profound
weight loss, fatigue and uncommon infections.  Continued destruction of the immune system leads to AIDS,
which is characterized by life-threatening opportunistic infections and cancers.  Based on detailed cohort studies,
primarily among white homosexual men in the USA, it is believed that the median period for the development of
severe immune deficiency that results in AIDS ranges from 8-10 years.
There was initial speculation that annual progression rates from HIV infection to AIDS were shorter on average
in females than males, and in developing countries compared with developed countries, but the limited data
available suggest that no major differences exist.
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The median interval from HIV infection to the development of severe immune deficiency appears to be similar in
all populations (i.e., in developed and developing countries) and is estimated to be about 7-8 years.  However,
there is a consensus that the survival period from the development of severe immune deficiency to death is much
shorter in most developing countries compared with developed countries, where the advent of HAART therapy
has significantly increased survival of patients with moderate immune deficiency related to their HIV infection.  A
recent review of cohort studies in Uganda, Thailand and Haiti indicates that the median interval from HIV
infection to death is 9 years.  This median period will now be uniformly used to calculate annual HIV incidence
and annual deaths due to immune deficiency related to HIV infection.
Of all host factors that have been studied, only age at acquisition of HIV infection appears to have a major effect
on progression to the development of AIDS.  A detailed analysis of annual progression to AIDS by age at HIV
acquisition for the HIV infected haemophilia cohort in the USA shows that younger members of this cohort
progress to AIDS more slowly than older men.  The average time to AIDS when infection was acquired after age
35 was about 7-8 years, while that for males who were initially infected when they were less than 35 years of age
was about 12 years.  Several female cohort studies in European countries, reported during the early 1990s,
indicate that age-specific progression rates in women are similar to those reported for men.
Survival time after diagnosis of AIDS and advent of anti-HIV treatment
The survival time after onset of severe AIDS-characteristic illnesses is also variable, but,  prior to the development
of effective anti-HIV therapy, average survival time was about 2-4 years in most developed countries and about 6
months or less in developing countries.  The shorter survival periods in developing regions was most likely due to
diagnosis at a later stage of disease and limited access to good supportive medical care.  In the absence of anti-
HIV drug treatment, the case/fatality rate attributable to HIV is among the highest of any human infectious
agent.
The proportion of HIV infected persons who, in the absence of anti-HIV treatment, will ultimately develop AIDS
has been estimated to be over 90%.  Less than 5% of HIV-infected persons who have been followed with detailed
clinical and laboratory studies for 10 years or longer have been classified as possible non-progressors.  In the
absence of effective anti-HIV treatment, the AIDS case-fatality rate is very high: most (80-90%) patients in
developed countries die within 2-4 years after the diagnosis of AIDS is made.  However, in the United States of
America and most developed countries, routine use of prophylactic drugs for the prevention of P. carinii pneumonia
and other opportunistic infections was able to delay the development of AIDS and death significantly, even prior
to the routine availability of effective anti-HIV treatment in the mid-1990s.  In Asia, routine access to effective
anti-HIV treatment is variable.  Access ranges from one extreme, such as in Hong Kong where triple anti-HIV
drug therapy is provided to all Hong Kong residents, to the other extreme in the poorer Asian countries, such as
Cambodia and Myanmar, where anti-HIV drug treatment is virtually unavailable.
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Mother-to-infant transmission of HIV
As of the start of the new millennium, our understanding of mother-to-infant transmission of HIV has improved greatly, especially regarding
the prominent role of breast-feeding.  During the late1980s and early 1990s, field studies consistently showed that mother-to-infant
transmission rates in Africa were almost twice as high as in Europe.  Even although breast-feeding was known to be a possible factor to
explain this marked difference in HIV transmission rates, there was great reluctance by most official agencies to accept this association with
breast-feeding without additional and more conclusive data.  By the mid-to-late 1990s, increasingly available data confirmed that breast-
feeding by HIV-infected mothers did not represent just a small increment of risk, but increased HIV transmission to their infants by up to
50%.  It is now mostly accepted that about 25% of HIV-infected pregnant females will transmit HIV infection to their infants – about 5% in
utero during gestation, about 15% around the delivery period, and about 10% in the postnatal period, primarily due to breast-feeding.
Treatment of pregnant women with anti-HIV drugs can result in a marked reduction of infant infections.  Up until mid-1999, the only drug
shown to reduce perinatal HIV transmission was zidovudine (ZDV), when administered in the following regimen.  First it had to be given
orally to the mother after 14 weeks gestation and continued throughout pregnancy, and then given intravenously to the mother during the
intrapartum period.  ZDV also had to be administered orally to the newborn infant for the first 6 weeks of life.  This complex chemoprophy-
lactic regimen was shown to reduce perinatal HIV transmission by over 60%.  A shorter course of ZDV treatment has subsequently been
shown to reduce the risk of perinatal transmission by about 40%.  A study reported from Uganda in July 1999 found that giving a single
dose of nevirapine to HIV infected females during labour, followed by a single dose to their newborn babies within 3 days of birth, gave
better results than both the long and short ZDV regimens.  Safer delivery practices (i.e., avoiding episiotomies and premature rupture of
membranes) have also been shown to be partially effective in reducing perinatal HIV transmission.  Finally, a programme of replacement
feeding of the infant (formula or wet-nursing from HIV-negative women) can increase prevention of HIV transmission via breast-feeding.
Although a short-term regimen of ZDV can significantly reduce the rates of mother-to-infant HIV transmission, by 18 months of age the
benefits to the infant of ZDV treatment are offset by infection via breast-feeding, according to the most recently available PETRA study data
released in early July 2000.  Conducted under the auspices of UNAIDS, the PETRA trial followed the outcome of 1754 HIV-infected
women and their infants after they were randomized to one of four arms.  These included ZDV and 3TC administered at 36 weeks
gestation and continued throughout 1 week after delivery (arm A); ZDV and 3TC intrapartum and throughout 1 week after delivery (arm
B); ZDV and 3TC intrapartum only (arm C); or placebo.  While both neonatal HIV transmission rates and mortality were significantly
reduced after 6 weeks of life in arm A and arm B compared with placebo, no significant difference in any of the study arms was seen after
18 months.  During the follow-up period, most of the participants were breast-feeding, which the researchers believe accounts for the high
number of HIV infections.  Thus, it is becoming increasingly clear that a combination of all of the best practices described above (safer
delivery procedures, including planned Caesarian section, anti-HIV drug treatment, and replacement feeding) are needed to significantly
reduce mother-to-child transmission of HIV –by up to 90%.
As a result of all of these findings, it is universally recommended that all pregnant women should be counselled about HIV early in
pregnancy and encouraged to be tested for HIV infection as a routine part of standard antenatal care.  HIV-positive females should be
given anti-HIV therapy to reduce in utero and perinatal HIV transmission.  ZDV is still relatively expensive, but nevirapine is less than $US
4.00 a dose, so the prospects of preventing mother-to-infant transmission of HIV may be less expensive in the new millennium.  However,
studies to confirm the effectiveness and safety of nevirapine are, as of mid-2000, still in progress.
Annex 2
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Prevention of mother-to-child transmission of HIV in the Asia Pacific region
The problem of paediatric AIDS and maternal AIDS orphans in the Asia Pacific region is diverse and difficult.  The estimated number of
paediatric AIDS cases and maternal AIDS orphans are directly related to the number of HIV-infected females of child-bearing age and their
fertility rates.  In addition, the number of HIV-infected mothers who breast-feed their infants will also affect the number of mother-to-child HIV
transmissions.
HIV prevalence is very low in most Asia Pacific countries and the predominant HIV-risk-behaviour populations are injecting drug users
(IDU), who are predominantly male, and sex workers and their male clients.  A relatively small “core” group of highly exposed female sex
workers (FSW) can develop very high HIV infection rates and transmit infection to their more numerous male clients.  This accounts for the
very large male preponderance of HIV infections in the early phase of a heterosexual HIV epidemic in Asian countries.  In the latter phases
of a heterosexual HIV epidemic, the male to female ratio begins to decrease as infected males begin to infect their steady female sex
partners (i.e., their wives or girlfriends).  The male to female ratio of HIV infections in most Asian countries is generally from 5:1 to 3:1 in
favour of males.  These factors (generally low HIV prevalence, a much higher male to female ratio of HIV infection), plus a much lower
fertility rate in Asia compared with sub-Saharan Africa, account for the relatively small numbers and prevalence of mother-to-child
transmission of HIV in Asia compared with Africa.
In the few high HIV prevalence countries in Asia (Myanmar, Thailand, Cambodia, and several states in India), however, up to 5-10% of
antenatal females in some areas have been infected with HIV.  In contrast, in most other Asian countries, estimated HIV prevalence in
antenatal females is generally about one infection per several thousand women.  The development of routine HIV testing and counselling
programmes for antenatal females in Asia is confronted with this very wide range in HIV prevalence between different Asian countries.
Without massive additional external support, Asian countries with current high HIV prevalence generally do not have the resources or
sufficiently developed medical or public health infrastructures to mount  routine national HIV testing, counselling, and treatment programmes
for the prevention of mother-to-child HIV transmission. Thailand is the current possible exception, but even Thailand is having difficulties
in marshalling all the needed resources and support for such a national programme.  Even if such a national programme were started in
Thailand, two additional and difficult HIV problems also need to be addressed at the outset.  Will anti-HIV treatment be made available to
the mother and the father of the child, and what replacement feeding, if any, will be provided to the child?
In low HIV prevalence Asian countries/city states that are more economically developed (i.e., Hong Kong, Japan, Macao, the Republic
of Korea and Singapore) a difficult programme decision needs to be made.  They need to decide whether HIV testing and counselling will
be routinely offered to all pregnant females, even when estimated HIV prevalence may be just one infection per several thousand women
tested.  Such a policy decision was made in Hong Kong and a comprehensive programme for routine offering of HIV testing for all antenatal
females, as well as provision of the most up-to-date drugs and other recommendations for the prevention of mother-to-infant transmission
of HIV, was started in 2001.
With the possible exception of the few high HIV prevalence countries in Asia, current and projected numbers of paediatric AIDS cases and
maternal AIDS orphans in Asia are relatively low and are expected to remain so.  However, regardless of what the actual numbers may
be, the problem of mother-to-child transmission of HIV will continue to be a vexing challenge to public health, health care and social support
systems throughout Asia.
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The reproductive number (Ro) of HIV
infections
The past, present and future prevalence of HIV infection can be understood more clearly by utilizing the concept of the reproductive
number of an infectious disease agent—designated Ro.  This relatively simple epidemiological concept describes, in a single value, the
epidemic potential of an infectious agent.  When, on average, one infected person infects more than one other person, Ro is greater than
1 and the result will be sustained or epidemic spread of the agent.  However, when, on average, one infected person does not infect more
than one other person, Ro is either 1 or <1 and epidemic spread does not occur.  When Ro is 1 or <1, the infectious agent will either
disappear or maintain itself in the population with zero or limited growth and become endemic.
Examples of the spread of an infectious agent where Ro is much greater than 1 are influenza and measles epidemics in a largely
susceptible population.  In such situations, one infected person at the start of an epidemic can easily infect scores of persons who in turn
infect scores more, so that Ro is very high.  Infected persons who recover are then immune to re-infection with the same infectious agent.
As the epidemic continues, the number of persons who have been infected and have become immune increases, while the number of
susceptible persons decreases.  Thus, Ro in these examples decreases over time and eventually becomes less than 1, and the infectious
agent either becomes endemic or dies out, depending on how rapidly new susceptible persons become available.  The epidemiological
dynamics of HIV infection are different because not everyone is at equal risk of HIV infection, and extensive transmission of HIV requires
specific patterns and networks of persons engaged in HIV-risk behaviour(s).
The average Ro of HIV via sexual transmission in a specific time period is dependent on:
• the risk of a sex contact being HIV positive (i.e., the prevalence of HIV in a sex network);
• the efficiency of HIV transmission per coital act;
• the number of different sex partners in a specific time period; and
• the number of unprotected coital acts with each of the above sex partner(s) in a specific time period.
Because the efficiency of HIV transmission per coital act is low, the Ro of HIV cannot be greater than 1 unless the number and frequency
of sex partner exchange is very high.  In populations (sex networks) where HIV prevalence is very low, a very high risk pattern and a
very high prevalence of heterosexual risk behaviours can be present without the Ro of HIV being greater than 1.  However, if HIV
prevalence is allowed to rise to a “high” level (arbitrarily up to 1%), then, depending on the underlying pattern(s) and prevalence of sex
partner exchange rates, Ro of HIV may increase to be greater than 1 – and if HIV prevalence is permitted to rise to 5%, it will make “self-
sustained” transmission of HIV (Ro more than 1) that much easier to reach for a given level of HIV-risk behaviour.
Annex 3
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With regard to HIV transmission, Ro among participants who engaged in sex partner exchange activities in gay bathhouses and among
injecting drug users in “shooting galleries” during the early 1980s was probably of the order of 5-6.  Ro for HIV in male haemophilia
patients (also for most other adults who received HIV-infected blood or blood products) and their steady sex partners has been
substantially below 1.  Ro for FSW and their male clients can be either <1 or > 1, and its value depends on sex partner exchange rates
and the presence or absence of many facilitating or inhibitory factors.
The concept of Ro and HIV transmission in different HIV RBG whose prevalence of HIV-risk behaviour differs can be illustrated by
reviewing HIV trends in Thailand from 1989 to 1999.  The Thai HIV sentinel surveillance data show very clearly that extensive HIV
transmission was essentially limited to the highest HIV RBG and to some of their regular sex partners.  After explosive increases in HIV
prevalence among IDU and FSW groups during the late 1980s and early 1990s, some limited transmission from infected male clients of
FSW and HIV-infected male IDU to some of their regular sex partners occurred.  However, since the mid-1990s, HIV prevalence levels
among antenatal females in Thailand have been slowly decreasing – from over 2% in 1994-1995 to 1.5% in 1998.  This decrease cannot
be totally attributed to the 100% condom programme that was implemented among FSW and their clients, because no marked increase in
condom use with their wives and steady girlfriends has been documented among Thai males.  At least part of this decrease is more likely
due to the fact that Ro between HIV infected Thai males and their steady sex partners is less than 1.
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Major determinants of heterosexual HIV
transmission
In about two-thirds of all countries in the world, HIV prevalence attributable to heterosexual transmission is less than one infection for every
thousand adolescents and adults 15-49 years of age.  However, in almost all countries in sub-Saharan Africa, several countries in the
Caribbean region, and a few countries in south and southeast Asia, HIV prevalence in heterosexual populations ranges from lows of about
1-2% to over 35%.  How can such large differences in HIV prevalence attributable to heterosexual transmission between countries with
high HIV prevalence (1% or greater) and most other countries be explained?  Answers may be found by examining the pattern(s) and
prevalence of sex partner exchange rates and the relative inefficiency of HIV transmission via unprotected sexual intercourse.  From the
beginning of the HIV/AIDS pandemic, the low infection rate of HIV per any single act of sexual intercourse (anal or vaginal) and the
paramount importance of quantitative and qualitative parameters of HIV-risk behaviours have not been fully appreciated by most policy-
makers, and many epidemiologists.
It is generally accepted that other STI, especially those that cause ulcerative lesions, such as chancroid and syphilis, increase the efficiency
of HIV transmission.  It is clear from many epidemiological studies that if an individual has an ulcerative genital lesion, the risk of HIV
transmission is increased.  However, no internationally accepted measures or indices have been developed to reliably quantify the
prevalence of STI between different countries.  STI prevalence surveys are difficult to conduct and data are limited to small, selected
Annex 4
*This region had the lowest STD rate, and all of the other regions are multiples of this lowest rate – i.e., the STD
rate in sub-Saharan Africa is 11.52 times greater than the STD rate in the East Asia and Pacific region.
**The Spearman rank difference correlation between HIV prevalence in 2000 and STD Index in 1998 for these 7
regions is: + 0.93.  The standard error for this correlation is 0.02.
  Adults     No. HIV    No.  STI Index
   15-49     HIV Rate    STI  Rate   STI
Region  (Millions) (Millions)  (%) (Millions)   (%) Index
Sub-Saharan Africa   273.53 23.40 8.56  69 25.23 11.52
Caribb & Latin Amer   269.13   1.55 0.58  38 14.12   6.45
South & SE Asia   993.47   5.40 0.54 151 15.20   6.94
“Western” countries   359.44   1.43 0.40  32   8.90   4.06
E Eur & Central Asia   197.72   0.41 0.21  22 11.13   5.08
N Africa & Mid-East   171.94   0.21 0.12  10   5.82   2.66
East Asia & Pacific   821.65   0.53 0.06  18   2.19   1.00*
Total 3086.88 32.93 1.07 340 11.01
Table 5: Estimated regional HIV and STD prevalence, end of 1999
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samples, mostly from STD clinics.  These limited data suggest that the prevalence of STI, especially those associated with ulcerative
lesions, is higher in populations with high heterosexual HIV prevalence than in countries with low heterosexual HIV prevalence.
Table 5 presents regional estimates of HIV prevalence, as of the end of 1999, together with a regional STD index, calculated from estimates
of regional STD prevalence made in 1998 9. This table shows a good correlation with HIV prevalence and a calculated STD index.  The
East Asia and Pacific region has the lowest STD prevalence rate and the lowest STD index, as well as the lowest estimated HIV
prevalence rate, whereas sub-Saharan Africa has the highest STD prevalence rate, highest STD index and highest estimated HIV
prevalence rate. The combination of the Caribbean and Latin America may partly obscure the probably higher STD rates in the
Caribbean.
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Understanding HIV/AIDS numbers
This section defines and describes the HIV/AIDS numbers commonly used by HIV/AIDS programmes in order to clarify potential
misunderstanding, especially for those health care workers and others who may not be familiar with the specific meaning of these
numbers.
The first cases of HIV infection or AIDS were imported into the Asia Pacific region in the early to mid-1980s.  At the beginning of public
health surveillance for HIV/AIDS in Asia Pacific countries, no distinction was made between prevalent and cumulative numbers of HIV
infection and/or AIDS.  However, with time and the progression of HIV infection to AIDS and death, the constant widening difference
between the prevalent number of HIV infection and the cumulative number became very obvious.  As of the beginning of the  new
millennium, cumulative numbers of HIV infection and/or AIDS cases are not commonly used, except to put HIV/AIDS epidemics in this
region into a historical perspective.  Public health programmes now almost exclusively use prevalent (those persons living with HIV at
a specific point in time) and incident (new HIV infections over a specified time period – usually a calendar year) numbers.
Since HIV is primarily a sexually transmitted infection, the prevalence of HIV is most frequently presented for the most sexually active age
group (15-49 years), and not for the total population.  The prevalence of HIV can be a number or rate (expressed as a percentage of
a specified population) of persons alive with an HIV infection.  Thus, if there are 2000 HIV infections in a population of 10 000 15-49 year-
olds, the prevalence of HIV in this 15-49 year-old population is 2000 or 20% (2000 divided by 10 000).  If there are 500 HIV infections
in persons outside of the 15-49 year-old age group and there are 15 000 persons in these other age groups, the HIV prevalence for
the total population would be 2500 or 10% (2500 divided by 25 000).  The latter HIV prevalence rate is rarely presented but, when it
is, this may be confusing to the public, who usually see the prevalence rate for the 15-49 year-old population as 20%.  Similarly, annual
HIV incidence or incidence rates are usually presented only for the 15-49 year-old population.  When presenting data for paediatric
AIDS or for maternal AIDS orphans, the age grouping is from 1 to 15 years.
A clear distinction also needs to be made for each of the following types of HIV/AIDS numbers – reported, official, estimated and actual.
As described in the section on public health surveillance,  the completeness and reliability of reported numbers of HIV infection and or
AIDS cases varies markedly from country to country and within any country there may be marked temporal variation in the accuracy
of reported HIV/AIDS.  Official numbers of HIV/AIDS may be reported cases or in some instances may be officially estimated cases.
Estimated numbers may be derived by a government-appointed expert group or can be the estimated number of an individual or an
Annex 5
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agency.  Some care needs to be taken in evaluating estimated numbers since, depending on the data, assumptions and method(s) used
to derive the estimate, the resultant figure can represent a reliable working estimate of the actual HIV/AIDS numbers or may represent
gross overestimation or underestimation of these numbers.  The actual or real numbers represent the “Holy Grail” for public health
epidemiologists.  The best approximation of the actual numbers can be derived via an objective estimation process, using the best data
available and reasonable assumptions and methods for the estimation process.
In general, HIV prevalence is usually derived or extrapolated from available HIV seroprevalence data and most of the other HIV/AIDS
numbers, including projections or forecasts of HIV/AIDS numbers are derived from scenario/modelling.
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Public health surveillance of HIV/AIDS
Public health surveillance can be defined as the collection, analysis and dissemination of data relevant to the prevention or control of a
public health problem.  The general methods used for public health surveillance of HIV infections and AIDS cases are, in general, no
different from those used for other diseases and infections.  However, the methods used must be adapted to the unique epidemiology, wide
variation in prevalence levels, and the very long incubation period of HIV infection prior to the development of AIDS.  In addition, the
severity of AIDS and the extreme social and personal implications of identifying HIV-infected persons make surveillance of HIV/AIDS much
more difficult and make issues such as anonymity and confidentiality of paramount importance.  Confidentiality of personal data is a
universally accepted concept, but anonymity in the public health management of any infectious or communicable disease is a new and
difficult concept to accept, especially in most countries in Asia.
Case reporting
Recognition, diagnosis and reporting of HIV/AIDS is generally very incomplete, so HIV infections and AIDS cases reported to health
authorities throughout the world constitute a variable and, usually, only a small fraction of the estimated total (i.e., “the tip of the iceberg”),
especially in developing countries.  Within Asia Pacific countries/city states, the estimated completeness of AIDS case reporting varies from
highs of 50% or more in places such as Hong Kong, to less than 5% in other Asia Pacific countries.  Reporting of HIV infections is usually
much more incomplete and inaccurate than AIDS case reporting, even in those countries where HIV reporting is required.  Therefore
reported AIDS cases and HIV infections should serve only as a starting point for estimation of actual HIV infections and AIDS cases that
have occurred.
HIV sentinel surveillance
Guidelines for Sentinel Surveillance of HIV (HSS) were initially developed by WHO in the late 1980s.  These broad guidelines were
developed primarily for countries in sub-Saharan Africa, where extensive heterosexual transmission was occurring.  The patterns and
prevalence of HIV in most Asia Pacific countries are quite different from those observed in Africa.  Thus, according to the UNAIDS/WHO
Guidelines for Second Generation HIV Surveillance, distributed in 2000, the WHO HSS Guidelines must be adapted to different HIV
patterns and prevalence rates in Asia Pacific countries.
Epidemiological data on HIV infections, collected since the mid-1980s, make it clear that multiple and, to a great extent, separate epidemics
of HIV infection can occur in any country or region, depending on the distribution and prevalence of specific HIV-risk behaviours, including
MSM, IDU who routinely share injecting equipment, and heterosexuals who have unprotected sex with multiple sex partners (HET).  HIV
surveillance systems need to be designed to monitor each of these relatively separate HIV epidemics.
HIV infections are not randomly distributed in any large population.  The public health surveillance strategy developed by WHO relied on
the routine and consistent collection of data from sentinel groups who could be considered representative of their group’s risk of acquiring
HIV infection.  The basic purpose of HSS is to detect changes (i.e., trends) in HIV prevalence in the sentinel groups selected.  If various
sentinel groups can be monitored consistently over time at selected sites, the data collected should provide reliable data on HIV trends in
these groups.  These data should be sufficient for the design and direction of HIV/AIDS prevention and control programmes.  The sentinel
populations selected should, to the extent possible, include all major HIV-risk behaviours or factors known to be prevalent in any given
population and/or area.
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HSS was not designed to collect data for the development of national HIV seroprevalence estimates.  However, HSS data have been used
for this purpose simply because there were no other HIV seroprevalence data sets available that might have been any better for this
purpose.  In addition alternative methods, such as community-based surveys are costly and difficult to carry out on a routine basis and may
also not be reliable.
Problems and limitations of HSS sentinel groups in Asia Pacific countries
Population groups considered to be at high risk of HIV infection because of their behaviour and selected as sentinel groups for HSS include
MSM, IDU and HET subgroups – FSW and sexually transmitted infection (STI) patients.  Lower-risk HET subgroups used in HSS
systems have included blood donors, military recruits and antenatal clinic attendees (ANC).  In addition, tuberculosis  patients have been
included in some HSS systems.  Uniform definitions for each sentinel group and rules for consistency in using them are essential for the
collection of reliable HSS data.
FSW
Studies in Thailand indicate that there are many different types of FSW in the country –from the direct brothel worker to the occasional
freelancer who may be picked up at bars or other locations.  In general, the average HIV risk for each type of FSW varies directly with
the average number of different sex partners each type may have on a daily or weekly basis.  Estimates of each type of FSW in any given
area are usually not made and different sentinel sites may target different types of FSW.
IDU
Similarly, not all drug users inject drugs, and not all injecting drug users routinely share their injecting equipment.  The heterogeneity of HIV
risk within these sentinel groups must be recognized.  Detailed guidelines should be provided to sentinel sites so that all sites are collecting
data from similar types of IDU subgroups.  In addition, the relative size of each specific IDU subgroup must be estimated when HIV
prevalence is estimated for the total IDU population.
Blood donors
Blood donors in most developed countries with a totally voluntary blood-donor system are considered a low HIV-risk group.  However,
in many Asia Pacific countries, depending on the utilization of paid donors, this population group may include persons with some increased
risk of HIV infection.  In addition, HIV prevalence among blood donors should decrease markedly when appropriate methods are
implemented prior to blood collection to screen out donors with possible high HIV-risk behaviours.
Military recruits
Young males who are drafted or volunteer for military service may in some countries be considered relatively representative of other
males who do not enter military service.  However, once in the military, these young men may increase their general patronage of FSW
and thereby increase their overall risk of acquiring an HIV infection.
Antenatal females
Pregnant females are an easily identified group from whom blood specimens can be collected routinely to monitor HIV prevalence.  In sub-
Saharan African countries, where the predominant mode of HIV transmission is heterosexual, HIV prevalence rates in antenatal females
have been used as a surrogate for HIV prevalence in the most sexually active (15-49 years of age) male and female population.  Some
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limited community-based HIV serological surveys of males and females in sub-Saharan African countries suggest that HIV prevalence
found in antenatal females is a reasonable surrogate for HIV prevalence in the sexually active population.  HIV prevalence was found to
be much higher in young antenatal girls than in other young girls and boys, while it was found to be much lower for pregnant women aged
25-39 compared with non-pregnant females in the same age group.  However, the average HIV prevalence in antenatal females was
close to the average HIV prevalence in males and females from the same general area.
Whether antenatal females in Asia Pacific countries can be used as reasonable surrogates for HIV prevalence in both males and females
in their communities remains an unanswered question as of 2001.  In addition, questions as to how representative antenatal females may
be of the general female population have been raised.  Females who become pregnant may differ from females who don’t become
pregnant because of factors that may be related to HIV infection.  HIV infection may reduce fertility progressively over time and HIV is often
associated with other STI known to cause infertility.
Tuberculosis patients
Tuberculosis patients have been included as sentinel groups in many HSS systems, but data from these patients are difficult to interpret
without a full understanding of the dynamic temporal interrelationship between Mycobacterium tuberculosis (Mtb) infection and HIV
infection.  Models of the interaction between HIV and Mtb infections provide useful estimates and projections of the additional tuberculosis
cases that may be expected annually in populations with different prevalence levels for these infections.  In sub-Saharan Africa, where
adult HIV prevalence levels are as high as 10-20% and the Mtb prevalence may exceed 50%, the annual number of adult tuberculosis
cases can be expected to increase by up to 10-fold during the new millennium.  Although the prevalence of Mtb infection among young
and middle-aged adults in most Asia Pacific countries is relatively high (from 25% to over 40%), adult HIV prevalence levels are much
lower and range from less than 0.1% to over 2%.  In Thailand, where adult HIV prevalence was estimated in 1995 to be over 2% and
where the adult prevalence of Mtb infection is about 35%, annual tuberculosis cases were projected to double by 2000.  In Hong Kong,
where adult HIV prevalence in 1995 was estimated to be less than 0.1% and prevalence of Mtb in adults was about 30%, the annual
increase in tuberculosis cases by 2000 was projected to be no more than about 2-3%.
Sampling Issues
The sampling method for HIV sentinel groups can best be described as a practical “grab” sample.  Most programmes have not provided
detailed guidelines to local or provincial health staff about how to select each annual or semi-annual sample.  In populations where there
are large numbers of FSW, IDU and male STI patients, it may not be difficult to obtain sufficient numbers of these risk groups in a short time
period.  However, in smaller populations, it may be very difficult, if not impossible, to collect the requested number, even if the time for
collection is extended and multiple sites are used.
Local sentinel sites may sometimes be changed from one HSS round to another, and occasionally even during the course of one HSS
collection period.  This raises the question of how to interpret differences in HIV prevalence from one HSS round to another.  Are the
differences due to real changes in HIV incidence over time in a given geographic location, or are differences related to variations in HIV
prevalence in the sentinel group sampled?  One of the major assumptions made in the interpretation of HSS results is that, if sample
collections are consistently uniform (i.e., same local sites, same sampling frame/method, etc.), then differences in HIV prevalence from one
HSS round to another might be attributed to HIV incidence in the sentinel group.  However, when HIV prevalence is relatively low (i.e.,
well below 1%), very wide fluctuations – as much as several-fold – may be found in any specific sentinel group.  Thus, calculation of
annual HIV incidence by subtracting last year’s estimated prevalence from the current year’s estimated prevalence can result in either a
positive or negative annual incidence of HIV infection.
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It must be stressed that HSS samples do not comprise a selected cohort (i.e., the same persons) who are sampled over time, but rather
a series of cross-sectional samples of a target population.  Additional potential biases in HSS data include possible different proportions of
urban versus rural samples collected from one round to another, and marked differences in the average age of those selected from one
round to another.
Behavioural surveillance
During the early 1990s, at the behest of international donors, increasing attention was given by WHO to the development of evaluation
indices for HIV/AIDS programmes.   However, methods for routine behavioural surveillance that should be implemented by HIV/AIDS
programmes were not developed by any major international agency.  The general concept of behavioural surveillance was not
formulated until 1993 and behavioural surveillance targeting selected risk groups has not, as of the late 1990s, been systematically and
routinely implemented in most national HIV/AIDS programmes.  Relatively large-scale population surveys of HIV-risk behaviours (KABP
surveys) have been developed and supported by WHO, but they did not support the development of periodic cross-sectional behavioural
surveys of HIV-risk behaviour groups.
It is now acknowledged that a significant amount of formative research may have to be undertaken before an efficient behavioural
surveillance system can even be set up.  This research, which aims to identify major HIV-risk behaviour subpopulations or groups to
develop appropriate behavioural questionnaires, and to construct sampling frames through which surveys might be administered, is being
developed by WHO and Family Health International (FHI).  In addition, UNAIDS and WHO are currently in the process of updating the
guide and methods package for monitoring and evaluating HIV and AIDS prevention and care programmes.  This joint guide will include
revised indicators and updated data collection instruments.  The choice of behavioural indicators may vary slightly according to the group
surveyed, but they will generally include:
• PI4 - Percentage of respondents who report at least one non-regular sex partner in the last 12 months; and
• PI5 - Percentage who say they used a condom the last time they had sex with a non-regular partner, of those who have had sex
with a non-regular partner in the last 12 months.
In addition, the following indicators may be considered in specific populations:
• Youth: age at first sex;
• Drug injectors: Reported sharing of unclean injecting equipment;
• Sex workers: Reported number of clients in last week;
• Sex workers: Reported condom use with last client.
Whether all national AIDS programmes in Asia need such detailed behavioural research studies or all of the behavioural indicators listed
above is open to question.  A more accurate surrogate measurement of P14 and P15 may be the prevalence of genital herpes (HSV
2
)
antibodies in young (20-24 years of age) antenatal females.  Described below are what may be the basic and essential behavioural data
needed by all AIDS prevention/control programmes in Asia.
The essential HIV-risk behaviour surveillance data needed by AIDS prevention and control programmes in all Asian-Pacific countries
include:
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• the patterns and prevalence of the highest-risk sexual behaviours; and
• the patterns and prevalence of sharing injecting equipment among injecting drug users.
There is a critical need to develop routine surveillance of these HIV-risk behaviours.  If public health programmes are to be effective in
reducing or at least modifying these behaviours, they must first obtain reliable baseline data on sexual and injecting drug behaviours in
population groups who are known to practice these behaviours.   The essential data needed for all high HIV-risk groups include:
• On average, how many different sexual partners did persons in this group have during the past month and/or week?
• For each of these sexual encounters, was a condom used?
Tabulation and analysis of the answers to these questions yields basic information that can provide programmes with:
• specific and reasonable targets that can be achieved over a specified period of time; and
• specific means of evaluating the effectiveness of programme interventions with regard to stated targets.
For example, if the targeted population were truck drivers, and the baseline behavioural surveillance survey indicated that this group had
an average of 3.5 different sex partners per month, with condom usage about 20%, then the programme could initially set programme
targets:
• to reduce the average number of sex contacts in this group to two per month or less; and
• to increase condom use to 50% over the next six months or a year.
Such programme objectives should be pursued regardless of whether HIV seroprevalence in the community is very low, moderate or
high.  A second behavioural survey six months or a year later can be used to measure whether or not programme targets have been
achieved, or if any changes have occurred.
Routine sexual behavioural surveillance surveys (not research studies or large KABP surveys) should be carried out on a regular basis
for all identified high HIV-risk behaviour groups.  For those persons who engage in injecting drug use, the essential behavioural questions
they need to be asked in addition to the two basic sexual behavioural questions are:
• With how many persons and how often, do you share drug injecting equipment during the past month and/or week?
• Do you use separate and/or clean injecting equipment when you share injection equipment?
The answers to these behavioural questions will provide public health programmes with data to develop targets for changing these
behaviours and to evaluate the effectiveness of education and other interventions in achieving these targets.  Public health epidemiologists,
in collaboration with behavioural scientists and experts, will need to develop and evaluate instruments (questionnaires, etc.) and methods
for the routine collection of behavioural surveillance data for specific populations.
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Methods for estimation/projection of HIV in-
fection and AIDS cases/deaths
The following section describes the limitations of the general methods used for estimating all the important and needed HIV/AIDS numbers
including:
prevalence, incidence and cumulative incidence of HIV infections;
prevalence, incidence and cumulative incidence of AIDS cases and AIDS deaths; and
prevalence, incidence and cumulative incidence of HIV-related diseases or conditions such as paediatric AIDS and maternal AIDS
orphans and HIV-related tuberculosis cases.
Methods for estimating HIV prevalence
(1) Prior to the advent of effective drug therapy to delay or prevent the relentless progression from HIV infection to the
development of AIDS, most developed countries considered reported AIDS cases to be sufficiently reliable for estimating HIV
prevalence by using a back-calculation method.  The back-calculation method used annual progression rates from HIV infection
to AIDS and reported annual AIDS cases (usually after adjustments for incomplete and delayed reports) to calculate how many
annual HIV infections would have been needed to generate the estimated annual AIDS cases.
(2) A “ratio” method that used an estimated ratio of prevalent HIV infections to prevalent AIDS cases was used in the late 1980s
and early 1990s to estimate HIV prevalence.  Like the back-calculation method, the ratio method required reliable estimates of
AIDS cases, which were generally not available.  In addition, most users of the ratio method did not realize that in all HIV
epidemics  the ratio of prevalent HIV infection to prevalent AIDS cases changes rapidly over time.  This HIV/AIDS ratio falls from
many thousands to one during the first few years of an HIV epidemic, to less than ten to one after the first decade.  This decline
occurs whether HIV incidence is increasing or decreasing because, in the absence of effective treatment, virtually all HIV-
infected individuals progress to AIDS.  Thus, at the start of any HIV epidemic, there are virtually no AIDS cases in the first few
years so that the HIV to AIDS case ratio is almost all HIV and no or few AIDS cases.  As the HIV epidemic continues, almost all
HIV infections will progress to AIDS and the HIV to AIDS case ratio will gradually decrease.  In a hypothetical situation, where
all HIV transmission is stopped, the HIV to AIDS case ratio will decrease to almost 1:1 because virtually all HIV infections
eventually progress to AIDS.
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(3)    A simple and useful method to estimate current HIV prevalence in a “mature” HIV epidemic (one that has been in progress for
about 10 years or longer) is to multiply the estimated annual AIDS cases by 20.  If the median period for HIV infection to the
development of AIDS is assumed to be 10 years, then about 10 years after the start of an HIV epidemic, about 5% of prevalent
HIV infections will develop AIDS on an annual basis.  For example, if the estimated annual number of AIDS cases is 5000, then
the estimated HIV prevalence would be about 100 000 (5000 multiplied by 20).  Conversely, if HIV prevalence is estimated to
be 100 000, then by taking 5% of the HIV prevalence one can rapidly calculate the expected annual number of AIDS cases to
be about 5000.  This is a “quick check and balance” method to see if the national estimate of HIV prevalence is compatible with
the estimated annual number of AIDS cases or the reverse – if the estimated annual number of AIDS cases “fits” with the
estimated national HIV prevalence.
(4)   In the absence of reliable AIDS case estimates or data, epidemiologists have estimated HIV prevalence by using the results of
serological surveys and extrapolating these data to the total 15-49 year-old population.  This has been and continues to be the
primary method used in developing countries to estimate HIV prevalence.  Major problems with this method are the limited
number of HIV seroprevalence studies that may be representative of specific populations or subgroups, and the wide variability
in estimates of the size(s) of important HIV-risk behaviour groups or cohorts, such as FSW, IDU and patients seen in STI clinics.
Nevertheless, epidemiologists have derived reasonable working estimates of the prevalence, general distribution and trends
of HIV infection for many countries by an objective and detailed analysis of all HIV serosurvey data and demographic data on
general population distribution.
Estimation of HIV prevalence by using HIV serological data
As of 2001, no uniform process and/or methods have been developed and distributed by UNAIDS or WHO to national AIDS programmes
for their estimation of HIV prevalence using available, but often limited HIV serological data.  As a result, many epidemiologists have
developed their own methods, assumptions and biases for using the available HIV serological data to derive a seroprevalence estimate.
Although HIV sentinel surveillance (HSS) systems were not designed to provide data for making HIV prevalence estimates, they have
been widely used for this purpose, simply because there are usually no better serological data available.  HIV/AIDS programmes have
routinely used HSS data to estimate HIV prevalence in the major sentinel groups.  HIV prevalence in the 15-49 year-old population has
been calculated according to the following general formulae:
(1) The number of HIV infections in each of the major high-risk groups = estimated HIV seroprevalence rate (from HSS data)
multiplied by the estimated number of the high-risk group (estimated for a specific population or a province); and
(2) The number of HIV infections in the 15-49 year-old population = estimated HIV seroprevalence rate in antenatal women
in the province (from HSS data) multiplied by the estimated number of 15-49 year-olds in the province (from census estimates).
Major Sources of Potential Error when Using this General Method :
(a) The data quality and representativeness of the usual grab samples collected for most HSS systems can be seriously ques-
tioned.  However, there have not been any systematic attempts to quantify the probable range of error(s) related to such data
quality issues.
(b) Errors in estimating the size(s) of specific RBG can be quite large (up to several times higher or lower).
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(c) The probable heterogeneity of HIV risk within any specific RBG is well known, but frequently findings from sentinel HIV sites that
tend to capture persons from those RBG with the highest or very high-risk behaviours are then extrapolated to the total RBG.
This obviously will tend to lead to higher HIV prevalence estimates.
(d) A major assumption used in this method is that HIV prevalence found in antenatal clinic attendees (ANC) can, with adjustment
for the estimated male to female (M:F) ratio, be used as a surrogate for HIV prevalence in the total 15-49 year-old population.
This assumption, used in sub-Saharan Africa, is supported by limited community-based HIV serosurveys, which suggest that
HIV seroprevalence among antenatal females is a reasonable surrogate value for HIV seroprevalence in the total 15-49 year-
old population in sub-Saharan Africa.  However, this assumption has not been validated for other populations.
(e) Measurement and/or estimation of the male to female (M:F) ratio of HIV infections has been carried out using a variety of
methods and assumptions.  In most epidemiological settings outside Africa (where there is a slight excess of infected females,
compared to males) there has been a consistent and fairly large preponderance of infected males compared with females.
However, many Asian countries do not factor in a M:F ratio in their process of estimating their national HIV seroprevalence and
this could result in a gross underestimation if ANC data are used without any adjustment to estimate HIV prevalence in both males
and females.  All HIV prevalence estimation processes should try to ensure that the overall HIV prevalence estimate is consistent
with the estimated M:F ratio.
(f) In heterosexual HIV epidemics in Africa, a marked urban-to-rural HIV differential, of up to 10-fold or more, was noted in the early
phase of HIV spread.  This differential narrowed markedly with time and after 10 years or more had been reduced to about 1-
2-fold.  One current assumption is that changes in the urban-to-rural HIV prevalence differentials in other developing country
populations follow the same general course as that which has been observed in Africa.  It is quite possible (and indeed
probable) that, in other regions, heterosexual transmission of HIV may remain more localized in the highest RBG in urban
centres and may penetrate or diffuse much more slowly (if at all) into most rural populations.  However, in the absence of any
substantive HIV prevalence data collected from truly rural populations, the assumption that there is no urban-to-rural preva-
lence differential for HIV seroprevalence in Asian populations, can result in very large and unsupported HIV prevalence
estimates.
Methods for Projecting HIV
There is an ancient Arabic saying – those who predict the future, lie, even if they think they are telling the truth.  This saying succinctly
sums up the great uncertainty in projecting the future, especially for a complex problem such as HIV transmission.  Nevertheless, attempts
to predict future trends and prevalence of HIV have been carried out with a very wide range of errors, using the following methods.
•  The Delphi survey method was developed in an attempt to improve the reliability of the judgments needed in relatively uncertain
situations, as well as to provide a means of quantifying such judgments.  Essentially, the Delphi method obtains educated
guesses from selected experts in a reiterative fashion, and then uses the average and range of the Delphi responses as
projections.  Major advantages of the Delphi method are speed and low cost.  However, it is difficult to select truly knowledgeable
experts (i.e., experienced quantitative epidemiologists who are familiar with the epidemiology of HIV and general demographics
of a specific country or population) to develop reliable estimates or projections of the number of HIV infections.  Furthermore,
estimates and projections made by the Delphi method may have extremely wide ranges.  This method should be used only for
populations where no data are available.
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•   Mathematical and computer/simulation models have been used to develop short and long-range projections of HIV prevalence.
However, such models should be used primarily for hypothesis testing - not for making estimates and projections of the annual
incidence/prevalence of HIV infection for a specific country or population(s).  That was the conclusion of an UK expert committee
that reviewed the situation in the UK in 1994.  The committee concluded that the general uncertainty of many of the needed input
parameters such, as the size of the risk groups as well as reliable data on their current sex partner exchange rates, made
estimation and projection of HIV/AIDS incidence and prevalence in the UK extremely uncertain.  As a result, they stated clearly
that model outputs should not be used for specific programme or policy development.  However, many international “experts”
and several international agencies have essentially ignored this sage advice and, as a result, some unrealistic HIV prevalence
estimates and projections of HIV have been inappropriately used in some countries for programme and policy development.
Method for short-term (less than 5 years) projection of AIDS cases/deaths
A simple scenario/modelling approach for estimation and projection of AIDS cases was developed during the late 1980s by the Surveil-
lance, Forecasting, and Impact Assessment (SFI) unit of the former Global Programme on AIDS (GPA) of the World Health Organization
(WHO).  This scenario/modelling approach or method can be used to provide working estimates and short-term projections of AIDS cases
and deaths for policy development and public health planning.  A scenario is an outline for any series of events, real or imagined.  HIV/
AIDS scenarios can be made up or constructed with or without models to “fit” the observed HIV/AIDS data and trends.  The following is
an outline of the general methods used in this scenario/modelling approach to develop working estimates and projections of HIV infections
and AIDS cases and deaths.
(1) Assemble and analyse available HIV seroprevalence data to estimate the most recent pattern(s), prevalence and trends of HIV
infection for a specific population.
(2) Based on these data and other epidemiological observations, different HIV patterns and prevalence levels (i.e., scenarios) can
be constructed with some confidence to the year 2005 for specific countries/populations.
(1) An AIDS model can be used to derive annual and cumulative estimates and projection of AIDS cases/deaths and other HIV-
related conditions, based on the general HIV scenario(s) constructed.
EPIMODEL is a simple microcomputer programme developed by WHO in the late 1980s to estimate past, current, and to make short-term
projections of AIDS cases and deaths in areas where AIDS case reporting was largely incomplete and unreliable.  EPIMODEL is still used
widely for this specific task.  Most problems encountered by users of EPIMODEL are associated with its misuse because, as a computer
programme, EPIMODEL accurately calculates input parameters supplied by the user.  Just as a calculator should not be held accountable
for preparing an inaccurate tax return, EPIMODEL should not be blamed for inaccurate estimates of AIDS cases.
The basic module of EPIMODEL uses estimates of HIV prevalence and distributes this prevalence by annual HIV-infected cohorts back
to the estimated start of the HIV epidemic along a selected epidemic curve.  EPIMODEL then applies annual progression rates from HIV
infection to the development of AIDS to each of the annual HIV cohorts to calculate annual numbers of adult AIDS cases and deaths.
EPIMODEL provides default values for several input parameters that may be considered appropriate for modelling HIV/AIDS in a sub-
Saharan African population, but all input parameters for EPIMODEL can be easily changed to better “fit” the specific population that is being
modelled.
HIV/AIDS in Asia and the Pacific Region 2001
85
   WHO
It must be recognized that, in any large population, the spread of HIV infection and the subsequent appearance of AIDS cases is usually
the consequence of several epidemics, i.e., in different “risk groups” or different geographical areas.  Each epidemic – whether it be among
persons with multiple sex partners, injecting drug users, in urban or in rural areas – has its own starting point and intensity of spread (force
of infection).  Each HIV epidemic should be modelled separately if sufficient epidemiological data are available.  It also needs to be
emphasized that EPIMODEL, and/or any other method or model for estimation and projection of AIDS cases, cannot be considered
precisely accurate.  EPIMODEL uses estimates of HIV seroprevalence, estimates of the shape and age of the HIV epidemic curve, and
estimates of average progression rates from infection to AIDS and death to derive its output.  All of these estimates have to be constantly
reviewed, and revised, as additional data become available.
EPIMODEL was not designed to provide projections of HIV infection.  However, short-term projections of AIDS cases are not greatly
affected by stopping or continuing HIV transmission after a specific year.  This is because 80% to 90% of AIDS cases that will be occurring
3 to 5 years after a reference year will be in persons who were infected as of the reference year.  However, major sources of potential
error in this simple model must be constantly reviewed.  Projections of AIDS cases for periods longer than 3 to 5 years can be produced
by EPIMODEL by assuming that annual HIV infections beyond the reference year will continue along the curve selected for use.
However, longer-term projections of AIDS cases using EPIMODEL, or any other model, are less reliable because they depend on
accurate projection of future HIV infections.
The basic module of EPIMODEL was designed to estimate and project adult AIDS cases and deaths.  This module can, with the additional
input of a population denominator, calculate annual incidence and prevalence rates for HIV infection.  Other modules of EPIMODEL include
a CHILD module that estimates and projects annual numbers of HIV-infected and uninfected infants born to HIV-infected women.  This
paediatric module also calculates paediatric AIDS cases and deaths, and the age of maternal orphans during the year of their mothers’
death.
During the early 1990s, a TUBERCULOSIS module of EPIMODEL was developed to estimate annual numbers of tuberculosis cases
related to HIV infections.  EPIMODEL divides the estimated annual cohort of adult HIV infections into two separate groups – those with
Mycobacterium tuberculosis (Mtbc) infection (Mtbc/HIV) and those without Mtbc infection.  Each group is progressed to AIDS with rates
that can be changed.  Increased rates for the development of tuberculosis can be applied to the Mtbc/HIV group to estimate the increased
number of tuberculosis cases as a result of HIV infection.
Aside from the potential errors described above, additional sources of potential error in using EPIMODEL include the following:
(1) The greatest error could occur in estimating HIV point prevalence.  This is not really an error of the model, but an extra word of
caution in selecting input parameters for EPIMODEL.  If a very high HIV seroprevalence estimate is used, the number of
resultant estimated AIDS cases will also be very high.
(2)  The “stage” of the HIV epidemic will have a significant impact on the estimates of annual HIV incidence and on estimates of annual
deaths due to severe immune deficiency related to HIV infection.  For a specific point prevalence estimate of HIV prevalence,
the estimated annual incidence of HIV infection will be greater in the early or increasing phase of an HIV epidemic than it will be
in the later or declining phase of an HIV epidemic.  The stage and duration of the modelled HIV epidemic will also have a major
impact on the estimated cumulative incidence of HIV infections and AIDS deaths.
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(3)  Another possible source of error in producing estimates and projections of AIDS cases and deaths with EPIMODEL is the
selection of the median interval period from HIV infection to death due to severe immunodeficiency related to HIV infection.  The
median interval from HIV infection to the development of severe immune deficiency appears to be similar in all populations (i.e.,
in developed and developing countries) and is estimated to be about 7-8 years.  However, there is a consensus that the
survival period from the development of severe immune deficiency to death is much shorter in most developing countries than
in developed countries, where the advent of HAART therapy has significantly increased survival of patients with moderate
immune deficiency related to their HIV infection.  A recent review of several cohort studies (Uganda, Thailand, and Haiti) indicate
that the median interval from HIV infection to death is 9 years, and this median period will now be uniformly used to calculate
annual HIV incidence and annual deaths due to immune deficiency related to HIV infection.  There is a deliberate movement by
UNAIDS/WHO to avoid estimation of AIDS cases because of the vagaries of AIDS definitions.
The default median progression period from infection to AIDS in EPIMODEL is 10 years and the default median interval from AIDS to death
for developing countries is less than 1 year.  This has resulted in a median interval from HIV infection to death of 11 years.  The change
from this 11-year median survival period to the 9-year median progression period from infection to death results in much higher (up to 30%
higher) cumulative numbers of HIV infections.  In addition, use of a 9-year median survival period results in a higher (up to 60% higher)
annual number of AIDS deaths.  This increase in annual deaths is needed to compensate for the increase in cumulative HIV infections.
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HIV trends in some specific countries in Asia
The use of HIV Sentinel Surveillance (HSS) data to monitor HIV trends can be illustrated by reviewing HSS data from all the high HIV
prevalence countries or areas in Asia (Thailand, Cambodia, Myanmar and Mumbai, India) and from a couple of low HIV prevalence
countries (Indonesia and the Philippines).
Figures 10 and 11 present findings from the Thai HSS system – from its beginning in 1989 up to and including the year 2000.  The Thai
HSS system was started in 1989 and was rapidly expanded to include all 76 provinces in the country.  Until the end of 1994, two semi-
annual rounds of HSS were carried out. Since then, a single annual round has been conducted  mid-year.  Sample sizes obtained for each
of the sentinel groups from each sentinel site generally range from about 100-300.  For each HSS round, a median value for each of the
sentinel groups (except military recruits) has been plotted in Figures 10 and 11.  For military recruits a mean value was used.
Very rapid and extensive HIV transmission occurred among IDU groups in Bangkok starting around 1986-1987.  Figure 10 show that,
by 1989, HIV prevalence had increased to about 30-40% among the IDU groups. That general prevalence was maintained throughout
the mid-1990s and has been steadily increasing since then to reach over 50% in 1999 and close to 50% in 2000.  At the start of HSS in
Thailand in 1989, HIV prevalence in direct, brothel-type FSW was about 5%, increased steadily to peak around the mid-1990s at over
30% and appears to have been slowly decreasing since then.  Figure 11 shows that HIV prevalence in all the lower HIV RBG (except
blood donors and antenatal clinic (ANC) attendees) reached levels of a few percent by 1989 and all appeared to peak around the mid-
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to-late 1990s. These HIV prevalence trends are clearly captured by the Thai HSS system, which is, by far, the most comprehensive HIV
surveillance system developed by any country in the world.
The Thai HSS data show clearly that extensive HIV transmission has essentially been limited to their highest HIV RBG.  After explosive
increases in HIV prevalence among IDU groups and FSW and their male clients during the late 1980s and early 1990s, some limited
transmission from infected male IDU and infected male clients of FSW to their wives and regular sex partners occurred.  Since the mid-
1990s, HIV prevalence levels among ANC attendees in Thailand has been slowly decreasing--from over 2% in 1994-1995 to about
1.5% in 2000.  Not all of this decrease can be attributed to the 100% condom programme, implemented among FSW and their clients,
because a marked increase in condom use has not occurred among Thai males with their regular sex partners.  The slowly decreasing
HIV prevalence in all of the lower-risk HIV sentinel groups is more likely due to a much lower frequency of sex partner exchange and
lower frequency of sexual contact.  As a result, the reproductive number of HIV in HIV-infected Thai males to their regular sex partners,
and from infected females to other sex partners, is less than 1.
HIV infections were first detected in Cambodia through serological screening of blood donors in the early 1990s.  However, the general
magnitude of HIV transmission in the country was not fully described until the completion of the first HSS round in 1995.  HIV sentinel groups
that year included eight different populations in nine provinces located mainly on the Thai border, where HIV infections were suspected
to be high.  The results provided the first evidence of a highly disseminated HIV epidemic with prevalence of HIV up to 38% among FSW,
8% among police and the military, and about 2.5% among women attending ANC.
Table 6 presents results of the expanded HSS in 1996 among three of the sentinel groups – FSW, soldiers and antenatal women.  These data
are presented to illustrate that, when HIV prevalence reaches levels of 40% or more, the sample size for HSS does not have to be several
hundred per site.  The smallest sample of FSW was 20 and seven HIV positives were detected in that sample.  The sample sizes of antenatal
women ranged from a low of 38 to a high of 452, but HIV was detected at all sites.  These findings clearly show that HIV prevalence reached
very high levels among FSW throughout Cambodia.  In addition, a relatively high HIV prevalence was found in male clients of FSW (soldiers
and police), some of whom are transmitting HIV to their wives and/or other regular sex partners.
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The estimated national HIV prevalence in Cambodia reached a high of over 3% in 1997 and 1998, but HSS data for 1999 and 2000
indicate that HIV prevalence has peaked.
HIV sentinel surveillance (HSS) was started in Myanmar in 1992 with a total of nine sites where data were collected on FSW who were
rounded up by the police, male STI patients, injecting drug users (IDU), and antenatal clinic attendees (ANC).  HSS was expanded to 19
sites in 1994, 21 sites in 1997 and, starting in 2001, a total of 27 sites will be included.
Extensive HIV transmission probably started in Myanmar during the late 1980s since, by 1992, HIV prevalence was already over 60%
among IDU and over 5% among FSW.  The HIV pattern and prevalence found in Myanmar is very similar to that found in Thailand.
However, a few major differences that began to develop after the mid-1990s should be noted.
• HIV prevalence peaked among direct and indirect FSW in Thailand starting around the mid-1990s and has been decreasing
since.  In Myanmar, a “100% condom programme” was started in a few townships late in 2000 and HIV prevalence rates
among FSW have been continuing to increase in recent years.
Source: MOH Cambodia
Table 6: HIV sentinel surveillance  results in selected provinces in Cambodia, 1996
 No.    No.     %     No.      No.   %     No.    No.    %
Province Tested  Pos.  Pos. Tested   Pos.  Pos   Tested Pos  Pos
Siem Reap  100    49   49.00      50     2    4.00    248     4    1.61
Battambang  156     91   58.33       56     4    7.14    180     8    4.44
Rattanakiri    20       7   35.00       79     1    1.27    113      7    6.19
Kampong Cham  152    42   27.27     136     9    6.62    232     2    0.86
Prey Veng    91    27   29.67     109     8    7.34    452     6    1.33
Svay Rieng    69    25   36.23     105     4    3.81    325     3    0.92
Takeo    69    17   24.64       94     4    4.26    218     2    0.92
Kampot    77    32   41.56       52     4    7.96    208     4    1.92
Kratie    77    22   28.57      NA     -      -     350     1    0.29
Stung Treng    60    10   16.67       74     3    4.05    264     2   0.76
Kampong Chhnang   116    45   38.79       96     1    1.04    258     3   1.16
Kampong Speu   115    58   50.43     169    8    4.73    210     3   1.43
Pursat   103    51   49.51       93  13  13.98     174     4     2.30
Kandal   105    14   13.33       78    2    2.56    200     6   3.00
Sihanouk ville    99    51   51.52       52    9   17.31     95      2    2.11
Koh Kong   119    62   52.10       17    2   11.76      38     2    5.26
Banteay Meanchey   156    85   54.49       92    6    6.52    178     3    1.69
Phnom Penh   173    72   41.62       77    5    6.49    186    6    3,23
TOTALS 1859   760   40.88    1429  85    5.95  3929   68    1.73
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• HIV prevalence among ANC in Thailand peaked at slightly over 2% around the mid-1990s and has been slowly declining to a
level of about 1.5% in the year 2000, whereas no peaking has been noted in the Myanmar ANC trend.
• Military recruits in Thailand also appeared to have peaked in the mid-1990s, while no peaking has been seen for Myanmar army
recruits.
All of the available HIV/AIDS data, including the results of HSS data, indicate that the peaking of HIV prevalence among FSW in Thailand
was a direct result of the “100% condom programme”.  This public health intervention was started by the Thai AIDS Programme for FSW
and their male clients during the early 1990s.  A “100% condom programme” was started on a pilot basis in late 2000 in four townships in
Myanmar, but it is too early for these pilot programmes to have had any measurable effect on HIV prevalence among FSW. The 2000 HSS
findings in Thailand and Myanmar show how similar the HIV patterns and prevalence in these two countries are.
HSS systems in all the countries or areas in Asia currently classified as having high HIV prevalence were started at varying times after
extensive HIV transmission began.  However, from the available HSS data, the general HIV pattern and the median or mean HIV
prevalence among FSW and ANC sentinel groups appear to be very similar, as shown in Figure 12.  In Thailand, the most detailed and
comprehensive HSS system was started in 1989, probably a few years after HIV had already started to spread among heterosexuals with
the highest sexual risk behaviours.  HIV prevalence among Thai FSW would likely have reached levels of 40% or higher had the 100%
condom intervention not been started in Bangkok during the early 1990s.  By the mid-1990s, HIV prevalence in Thailand had peaked at
about 34% and has decreased markedly to below 20% by the late 1990s, although a possible levelling or increase occurred in 2000.  As
noted previously, HIV prevalence in Thai ANC populations also peaked around the mid-1990s at slightly over 2% and decreased to less
than 1.5% in 2000.
In all the other high HIV prevalence countries/city, HIV prevalence in FSW have reached levels of close to 40% or higher.  The HIV
prevalence trend among FSW in Myanmar appears to be still increasing whereas, in both Cambodia and Mumbai, there is some
suggestion that HIV prevalence may have peaked in their FSW populations.  HIV prevalence in all of the ANC sentinel populations has
appeared to be levelling or decreasing slightly during the last few years.  Cambodia, which currently has the highest estimated HIV
prevalence rate (2.8%) in Asia, has the highest ANC prevalence rate (close to 3%), whereas all the other high HIV prevalence
populations in Asia have HIV prevalence rates of from 1.5% to a little over 2%.
All of these findings are consistent with an initial explosive increase of HIV prevalence from relatively small numbers of infected FSW to their
more numerous male clients.  Subsequently, infected male clients have transmitted their infection, to only a limited extent, to their regular sex
partner(s). Thereafter, HIV penetration into the general heterosexual population has not continued at any measurable rate.  The
decreasing trend of HIV prevalence in FSW and ANC sentinel populations in Thailand is convincing support for the effectiveness of the
100% condom intervention strategy.  However, decreasing HIV prevalence trends cannot be expected in other countries/areas until they
fully implement the 100% condom programme for all commercial and casual sex encounters.
In low HIV prevalence countries, such as Indonesia and the Philippines, HIV infection was not found in large numbers of FSW during the
1990s.  In the Philippines, annual HSS samples of about 300 FSW from 8-10 sentinel sites throughout the country have only detected
occasional and sporadic HIV infections.
The limited HSS data from Indonesia have been similar to those found in the Philippines – a survey of close to 2000 FSW in the late 1990s
from a few selected areas of Indonesia detected no HIV infection.  In the Philippines and Indonesia, HIV prevalence in FSW continues, as
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of 2001, to be low.  These findings clearly indicate that extensive heterosexual HIV transmission has not occurred, even within the highest
heterosexual RBG.  However, the most recent HIV surveillance data from Indonesia for the years 1999-2000 indicate that HIV prevalence
rates are rising rapidly among IDU populations throughout the country and HIV prevalence is now detectable (1-5%) in several FSW
populations.
HSS data from the Philippines are adequate to conclude that extensive transmission of HIV has not occurred in the country.  If HIV
prevalence in FSW in the Philippines were a few percent or more, then even the most limited HSS system would be able to detect such
a prevalence level.  The 1996 HSS findings in Cambodia (Table 2), show very clearly that HIV prevalence levels of 1-2% in ANC females
were readily detected with relatively small sample sizes.  The fact that sample sizes of about 300 FSW from sentinel sites in the Philippines
have not detected many HIV infections should be considered adequate to conclude that HIV has not yet spread extensively in the highest
heterosexual RBG – FSW and their male clients.
In many developed countries, HIV seroprevalence in MSM and IDU reached more than 10% within a few years after initial introduction,
whereas in the same areas, HIV prevalence in the highest-risk heterosexuals (FSW and their clients) are still virtually undetectable or are
not consistently found.  HSS, as designed by WHO/GPA during the late 1980s, has been a relatively reliable method for monitoring the
general patterns and trends of HIV infection.  HSS can provide an early warning alert of HIV transmission in the highest HIV RBG, and
can also provide a very rough measurement of overall HIV prevalence in these RBG.  HSS was not designed for making estimates of
national HIV prevalence.  However, HSS data are sufficiently reliable to confidently estimate HIV prevalence rates in the 15-49 year-old
population to be very low (less than 0.1%) or high (more than 1%).
   WHOHIV/AIDS in Asia and the Pacific Region 2001
92
References
1 . Padian NS et al.  Heterosexual transmission of human immunodeficiency virus (HIV) in northern
California: results from a ten-year study.  American Journal of Epidemiology, 146(4): 350-7, Aug 15,
1997.
2 . Gray RH et al and the Rakai Project Team. Probability of HIV-1 transmission per coital act in mo-
nogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. The Lancet, Vol. 357 :1149-
1153. April.14, 2001.
3 . Chin J, Bennett A, Mills S.  Primary determinants of HIV prevalence in Asia Pacific countries.  AIDS,
12 (suppl B): S87-S91, 1998.
4 . de Vincenzi I, Mertens T. Male circumcision: a role in HIV prevention? AIDS , 8(2): 153-160, 1994.
5 . Halperin DT, Bailey RC. Male circumcision and HIV infection: 10 years and counting. The Lancet,
354:1813-5, 1999.
6 . Weniger B et al. The molecular epidemiology of HIV in Asia 1994, AIDS, 8 (suppl 2): S13-S28.
7 . Havanon N, Bennett T, Knodel J. Sexual networking in provincial Thailand.  Studies in family plan-
ning, 24: 1-17, 1993.
8 . Cleland J, Ferry B (eds). Sexual Behaviour and AIDS in the Developing World.  London, Taylor and
Francis, 1995.
9 . Gerbase AC et al. Global prevalence and incidence estimates of selected curable STDs. Sexually
transmitted infections, 74 Suppl 1:S12-6, June 1998.

   WHOHIV/AIDS in Asia and the Pacific Region 2001
94
WORLD HEALTH ORGANIZATION
Price:  Sw.fr.5.00
In developing countries:  Sw.fr.3.50
ISBN 929061 158 8
Regional Office for South-East Asia
STI, HIV and AIDS Focus
World Health House, Indraprastha Estate
Mahatma Gandhi Road
New Delhi  110002 India
Fax: (91) 11-331-8607, 11-332-7972
Tel: (91) 11-331-7804, 11-331-7823
E-mail: postmaster@whosea.org
narainj@whosea.org
Web site: www.whosea.org/
Regional Office for the Western Pacific
STI, HIV and AIDS Focus
United Nations Avenue
(P.O. Box 2932)
1000 Manila, Philippines
Fax: (632) 521-1036, 526-0279, 526-0362
Tel: (632) 528-8001
E-mail: HSI@wpro.who.int
Web site: www.wpro.who.int
